The	O
ubiquitous	B-protein
octamer-binding	I-protein
protein	I-protein
(	O
s	O
)	O
is	O
sufficient	O
for	O
transcription	O
of	O
immunoglobulin	B-DNA
genes	I-DNA
.	O

All	O
immunoglobulin	B-DNA
genes	I-DNA
contain	O
a	O
conserved	O
octanucleotide	B-DNA
promoter	I-DNA
element	I-DNA
,	O
ATGCAAAT	O
,	O
which	O
has	O
been	O
shown	O
to	O
be	O
required	O
for	O
their	O
normal	O
B-cell-specific	O
transcription	O
.	O

Proteins	O
that	O
bind	O
this	O
octamer	O
have	O
been	O
purified	O
,	O
and	O
cDNAs	B-DNA
encoding	O
octamer-binding	B-protein
proteins	I-protein
have	O
been	O
cloned	O
.	O

Some	O
of	O
these	O
proteins	O
(	O
referred	O
to	O
as	O
OTF-2	B-protein
)	O
are	O
lymphoid	O
specific	O
,	O
whereas	O
at	O
least	O
one	O
other	O
,	O
and	O
possibly	O
more	O
(	O
referred	O
to	O
as	O
OTF-1	B-protein
)	O
,	O
is	O
found	O
ubiquitously	O
in	O
all	O
cell	O
types	O
.	O

The	O
exact	O
role	O
of	O
these	O
different	O
proteins	O
in	O
directing	O
the	O
tissue-specific	O
expression	O
of	O
immunoglobulin	B-DNA
genes	I-DNA
is	O
unclear	O
.	O

We	O
have	O
identified	O
two	O
human	B-cell_line
pre-B-cell	I-cell_line
lines	I-cell_line
that	O
contain	O
extremely	O
low	O
levels	O
of	O
OTF-2	B-protein
yet	O
still	O
express	O
high	O
levels	O
of	O
steady-state	B-RNA
immunoglobulin	I-RNA
heavy-chain	I-RNA
mRNA	I-RNA
in	O
vivo	O
and	O
efficiently	O
transcribe	O
an	O
immunoglobulin	B-DNA
gene	I-DNA
in	O
vitro	O
.	O

Addition	O
of	O
a	O
highly	O
enriched	O
preparation	O
of	O
OTF-1	B-protein
made	O
from	O
one	O
of	O
these	O
pre-B	B-cell_line
cells	I-cell_line
or	O
from	O
HeLa	B-cell_line
cells	I-cell_line
specifically	O
stimulated	O
in	O
vitro	O
transcription	O
of	O
an	O
immunoglobulin	B-DNA
gene	I-DNA
.	O

Furthermore	O
,	O
OFT-1	O
appeared	O
to	O
have	O
approximately	O
the	O
same	O
transactivation	O
ability	O
as	O
OTF-2	B-protein
when	O
normalized	O
for	O
binding	O
activity	O
.	O

These	O
results	O
suggest	O
that	O
OTF-1	B-protein
,	O
without	O
OTF-2	B-protein
,	O
is	O
sufficient	O
for	O
transcription	O
of	O
immunoglobulin	B-DNA
genes	I-DNA
and	O
that	O
OTF-2	B-protein
alone	O
is	O
not	O
responsible	O
for	O
the	O
B-cell-specific	O
regulation	O
of	O
immunoglobulin	B-DNA
gene	I-DNA
expression	O
.	O

MoLEcULAR	NULL
anp	NULL
CELLULAR	NULL
BioLOGY	NULL
,	NULL
Mar	NULL
.	NULL

1990	NULL
,	NULL
p.	NULL
982-990	NULL
0270-7	NULL
Copyright	NULL
©	NULL
1990	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

10	NULL
,	NULL
No	NULL
.	NULL

3	NULL
The	NULL
Ubiquitous	NULL
Octamer-Binding	NULL
Protein	NULL
(	NULL
s	NULL
)	NULL
Is	NULL
Sufficient	NULL
for	NULL
Transcription	NULL
of	NULL
Immunoglobulin	NULL
Genes	NULL
DAVID	NULL
G.	NULL
JOHNSON	NULL
,	NULL
LEON	NULL
CARAYANNOPOULOS	NULL
,	NULL
J.	NULL
DONALD	NULL
CAPRA	NULL
,	NULL
PHILIP	NULL
W.	NULL
TUCKER	NULL
,	NULL
*	NULL
AND	NULL
JEFFREY	NULL
H.	NULL
HANKEt	NULL
Department	NULL
of	NULL
Microbiology	NULL
,	NULL
Southwestern	NULL
Medical	NULL
Center	NULL
at	NULL
Dallas	NULL
,	NULL
Dallas	NULL
,	NULL
Texas	NULL
75235-9096	NULL
Received	NULL
30	NULL
August	NULL
1989/Accepted	NULL
30	NULL
November	NULL
1989	NULL
All	NULL
immunoglobulin	NULL
genes	NULL
contain	NULL
a	NULL
conserved	NULL
octanucleotide	NULL
promoter	NULL
element	NULL
,	NULL
ATGCAAAT	NULL
,	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
required	NULL
for	NULL
their	NULL
normal	NULL
B-cell-specific	NULL
transcription	NULL
.	NULL

Proteins	NULL
that	NULL
bind	NULL
this	NULL
octamer	NULL
have	NULL
been	NULL
purified	NULL
,	NULL
and	NULL
cDNAs	NULL
encoding	NULL
octamer-binding	NULL
proteins	NULL
have	NULL
been	NULL
cloned	NULL
.	NULL

Some	NULL
of	NULL
these	NULL
proteins	NULL
(	NULL
referred	NULL
to	NULL
as	NULL
OTF-2	NULL
)	NULL
are	NULL
lymphoid	NULL
specific	NULL
,	NULL
whereas	NULL
at	NULL
least	NULL
one	NULL
other	NULL
,	NULL
and	NULL
possibly	NULL
more	NULL
(	NULL
referred	NULL
to	NULL
as	NULL
OTF-1	NULL
)	NULL
,	NULL
is	NULL
found	NULL
ubiquitously	NULL
in	NULL
all	NULL
cell	NULL
types	NULL
.	NULL

The	NULL
exact	NULL
role	NULL
of	NULL
these	NULL
different	NULL
proteins	NULL
in	NULL
directing	NULL
the	NULL
tissue-specific	NULL
expression	NULL
of	NULL
immunoglobulin	NULL
genes	NULL
is	NULL
unclear	NULL
.	NULL

We	NULL
have	NULL
identified	NULL
two	NULL
human	NULL
pre-B-cell	NULL
lines	NULL
that	NULL
contain	NULL
extremely	NULL
low	NULL
levels	NULL
of	NULL
OTF-2	NULL
yet	NULL
still	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
steady-state	NULL
immunoglobulin	NULL
heavy-chain	NULL
mRNA	NULL
in	NULL
vivo	NULL
and	NULL
efficiently	NULL
transcribe	NULL
an	NULL
immunoglobulin	NULL
gene	NULL
in	NULL
vitro	NULL
.	NULL

Addition	NULL
of	NULL
a	NULL
highly	NULL
enriched	NULL
preparation	NULL
of	NULL
OTF-1	NULL
made	NULL
from	NULL
one	NULL
of	NULL
these	NULL
pre-B	NULL
cells	NULL
or	NULL
from	NULL
HeLa	NULL
cells	NULL
specifically	NULL
stimulated	NULL
in	NULL
vitro	NULL
transcription	NULL
of	NULL
an	NULL
immunoglobulin	NULL
gene	NULL
.	NULL

Furthermore	NULL
,	NULL
OFT-1	NULL
appeared	NULL
to	NULL
have	NULL
approximately	NULL
the	NULL
same	NULL
transactivation	NULL
ability	NULL
as	NULL
OTF-2	NULL
when	NULL
normalized	NULL
for	NULL
binding	NULL
activity	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
OTF-1	NULL
,	NULL
without	NULL
OTF-2	NULL
,	NULL
is	NULL
sufficient	NULL
for	NULL
transcription	NULL
of	NULL
immunoglobulin	NULL
genes	NULL
and	NULL
that	NULL
OTF-2	NULL
alone	NULL
is	NULL
not	NULL
responsible	NULL
for	NULL
the	NULL
B-cell-specific	NULL
regulation	NULL
of	NULL
immunoglobulin	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
octamer	NULL
motif	NULL
,	NULL
ATGCAAAT	NULL
(	NULL
8	NULL
,	NULL
33	NULL
)	NULL
,	NULL
has	NULL
been	NULL
found	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
eucaryotic	NULL
regulatory	NULL
elements	NULL
,	NULL
including	NULL
promoters	NULL
,	NULL
enhancers	NULL
,	NULL
and	NULL
origins	NULL
of	NULL
replication	NULL
.	NULL

Some	NULL
of	NULL
these	NULL
elements	NULL
are	NULL
constitutively	NULL
active	NULL
in	NULL
all	NULL
cell	NULL
types	NULL
,	NULL
whereas	NULL
others	NULL
direct	NULL
cell	NULL
cycle-regulated	NULL
or	NULL
tissue-specific	NULL
activity	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
the	NULL
small	NULL
nuclear	NULL
RNA	NULL
genes	NULL
and	NULL
the	NULL
histone	NULL
H2b	NULL
gene	NULL
,	NULL
deletion	NULL
of	NULL
the	NULL
octamer	NULL
greatly	NULL
reduces	NULL
transcription	NULL
and	NULL
,	NULL
in	NULL
the	NULL
latter	NULL
case	NULL
,	NULL
also	NULL
eliminates	NULL
cell	NULL
cycle	NULL
regulation	NULL
(	NULL
1	NULL
,	NULL
10	NULL
,	NULL
22	NULL
,	NULL
42	NULL
)	NULL
.	NULL

In	NULL
both	NULL
the	NULL
heavy-	NULL
and	NULL
light-chain	NULL
immunoglobulin	NULL
gene	NULL
promoters	NULL
and	NULL
in	NULL
the	NULL
heavy-chain	NULL
enhancer	NULL
,	NULL
an	NULL
intact	NULL
octamer	NULL
hs	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
necessary	NULL
to	NULL
direct	NULL
B-cell-specific	NULL
transcription	NULL
(	NULL
8	NULL
,	NULL
12	NULL
)	NULL
.	NULL

Several	NULL
proteins	NULL
that	NULL
specifically	NULL
bind	NULL
the	NULL
octamer	NULL
sequence	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
mammalian	NULL
cells	NULL
.	NULL

One	NULL
such	NULL
protein	NULL
,	NULL
termed	NULL
octamer	NULL
transcription	NULL
factor	NULL
(	NULL
OTF-1	NULL
;	NULL
also	NULL
called	NULL
oct-1	NULL
,	NULL
NFA-1	NULL
,	NULL
OBP100	NULL
,	NULL
and	NULL
NF	NULL
III	NULL
)	NULL
,	NULL
is	NULL
found	NULL
in	NULL
all	NULL
tissue	NULL
types	NULL
tested	NULL
;	NULL
at	NULL
least	NULL
one	NULL
other	NULL
,	NULL
termed	NULL
OTF-2	NULL
(	NULL
also	NULL
called	NULL
oct-2	NULL
and	NULL
NFA-2	NULL
)	NULL
,	NULL
is	NULL
found	NULL
almost	NULL
exclusively	NULL
in	NULL
lymphoid	NULL
cells	NULL
(	NULL
23	NULL
,	NULL
32	NULL
,	NULL
37	NULL
,	NULL
45	NULL
,	NULL
46	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
several	NULL
cDNAs	NULL
encoding	NULL
these	NULL
octamer-binding	NULL
proteins	NULL
have	NULL
been	NULL
isolated	NULL
from	NULL
both	NULL
B-cell	NULL
lines	NULL
and	NULL
a	NULL
teratocarcinoma	NULL
cell	NULL
line	NULL
(	NULL
4	NULL
,	NULL
29	NULL
,	NULL
39	NULL
,	NULL
47	NULL
)	NULL
.	NULL

Sequence	NULL
analyses	NULL
of	NULL
these	NULL
cDNAs	NULL
reveal	NULL
that	NULL
these	NULL
genes	NULL
belong	NULL
to	NULL
an	NULL
even	NULL
larger	NULL
group	NULL
of	NULL
DNA-binding	NULL
proteins	NULL
called	NULL
the	NULL
POU	NULL
fam-ily	NULL
.	NULL

The	NULL
POU	NULL
family	NULL
of	NULL
proteins	NULL
also	NULL
includes	NULL
the	NULL
Pit-1	NULL
protein	NULL
,	NULL
which	NULL
is	NULL
expressed	NULL
in	NULL
pituitary	NULL
cells	NULL
and	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
transactivation	NULL
of	NULL
growth	NULL
hormone	NULL
and	NULL
prolactin	NULL
genes	NULL
,	NULL
and	NULL
the	NULL
unc-86	NULL
protein	NULL
,	NULL
which	NULL
is	NULL
a	NULL
nematode	NULL
gene	NULL
product	NULL
involved	NULL
in	NULL
neuronal	NULL
development	NULL
(	NULL
2	NULL
,	NULL
9	NULL
,	NULL
16	NULL
)	NULL
.	NULL

All	NULL
of	NULL
these	NULL
genes	NULL
contain	NULL
a	NULL
conserved	NULL
homeobox	NULL
domain	NULL
,	NULL
shown	NULL
to	NULL
be	NULL
important	NULL
in	NULL
DNA	NULL
binding	NULL
through	NULL
its	NULL
helix-turn-helix	NULL
motif	NULL
,	NULL
and	NULL
a	NULL
POU-specific	NULL
domain	NULL
of	NULL
unknown	NULL
function	NULL
but	NULL
which	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
contributing	NULL
to	NULL
DNA-binding	NULL
activity	NULL
(	NULL
21	NULL
,	NULL
48	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
their	NULL
structural	NULL
relatedness	NULL
,	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

+	NULL
Present	NULL
address	NULL
:	NULL
Central	NULL
Research	NULL
,	NULL
Department	NULL
of	NULL
Molecular	NULL
Genetics	NULL
,	NULL
Pfizer	NULL
,	NULL
Inc.	NULL
,	NULL
Groton	NULL
,	NULL
CT	NULL
06340	NULL
.	NULL

982	NULL
the	NULL
four	NULL
identified	NULL
POU	NULL
proteins	NULL
also	NULL
seem	NULL
to	NULL
be	NULL
related	NULL
functionally	NULL
.	NULL

At	NULL
least	NULL
three	NULL
(	NULL
OTF-1	NULL
,	NULL
OTF-2	NULL
,	NULL
and	NULL
Pit-1	NULL
)	NULL
are	NULL
transcriptional	NULL
transactivators	NULL
and	NULL
bind	NULL
to	NULL
similar	NULL
sequences	NULL
,	NULL
whereas	NULL
OTF-2	NULL
,	NULL
Pit-1	NULL
,	NULL
and	NULL
the	NULL
unc-86	NULL
protein	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
direct	NULL
tissue-specific	NULL
activities	NULL
(	NULL
for	NULL
reviews	NULL
,	NULL
see	NULL
reference	NULL
14	NULL
)	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
OTF-2	NULL
is	NULL
found	NULL
only	NULL
in	NULL
lymphoid	NULL
cells	NULL
and	NULL
that	NULL
the	NULL
octamer	NULL
is	NULL
conserved	NULL
in	NULL
all	NULL
immunoglobulin	NULL
promoters	NULL
examined	NULL
has	NULL
led	NULL
to	NULL
the	NULL
hypothesis	NULL
that	NULL
this	NULL
protein	NULL
mediates	NULL
the	NULL
tissue	NULL
specificity	NULL
of	NULL
immunoglobulin	NULL
gene	NULL
expression	NULL
.	NULL

Recent	NULL
evidence	NULL
,	NULL
however	NULL
,	NULL
suggests	NULL
that	NULL
OTF-1	NULL
can	NULL
transactivate	NULL
immunoglobulin	NULL
gene	NULL
promoters	NULL
in	NULL
vitro	NULL
(	NULL
25	NULL
)	NULL
.	NULL

In	NULL
that	NULL
report	NULL
,	NULL
crude	NULL
preparations	NULL
of	NULL
octamer-binding	NULL
proteins	NULL
were	NULL
made	NULL
from	NULL
HeLa	NULL
cells	NULL
,	NULL
which	NULL
contain	NULL
almost	NULL
exclusively	NULL
OTF-1	NULL
,	NULL
and	NULL
from	NULL
BJA-B	NULL
cells	NULL
,	NULL
a	NULL
B-cell	NULL
line	NULL
containing	NULL
high	NULL
levels	NULL
of	NULL
OTF-2	NULL
.	NULL

When	NULL
either	NULL
of	NULL
these	NULL
preparations	NULL
was	NULL
added	NULL
to	NULL
HeLa	NULL
or	NULL
B-cell	NULL
nuclear	NULL
extracts	NULL
depleted	NULL
of	NULL
octamer-binding	NULL
proteins	NULL
,	NULL
stimulation	NULL
of	NULL
immunoglobulin	NULL
gene	NULL
transcription	NULL
in	NULL
vitro	NULL
occurred	NULL
.	NULL

These	NULL
results	NULL
differ	NULL
from	NULL
other	NULL
reports	NULL
suggesting	NULL
that	NULL
only	NULL
OTF-2	NULL
,	NULL
and	NULL
not	NULL
OTF-1	NULL
,	NULL
functions	NULL
to	NULL
stimulate	NULL
immunoglobulin	NULL
gene	NULL
transcription	NULL
(	NULL
39	NULL
,	NULL
40	NULL
)	NULL
.	NULL

To	NULL
resolve	NULL
these	NULL
conflicts	NULL
and	NULL
further	NULL
examine	NULL
the	NULL
role	NULL
of	NULL
the	NULL
different	NULL
OTFs	NULL
in	NULL
immunoglobulin	NULL
gene	NULL
expression	NULL
,	NULL
an	NULL
in	NULL
vitro	NULL
transcription	NULL
system	NULL
was	NULL
developed	NULL
.	NULL

Using	NULL
nuclear	NULL
extracts	NULL
from	NULL
cell	NULL
lines	NULL
containing	NULL
varied	NULL
ratios	NULL
of	NULL
OTF-1	NULL
to	NULL
OTF-2	NULL
,	NULL
we	NULL
show	NULL
that	NULL
the	NULL
level	NULL
of	NULL
OTF-2	NULL
in	NULL
lymphoid	NULL
cells	NULL
does	NULL
not	NULL
correspond	NULL
to	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
cells	NULL
to	NULL
transcribe	NULL
an	NULL
immunoglobulin	NULL
gene	NULL
in	NULL
vitro	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
show	NULL
that	NULL
a	NULL
highly	NULL
purified	NULL
preparation	NULL
of	NULL
OTF-1	NULL
can	NULL
specifically	NULL
transactivate	NULL
an	NULL
immunoglobulin	NULL
gene	NULL
when	NULL
added	NULL
to	NULL
lymphoid	NULL
nuclear	NULL
extracts	NULL
but	NULL
does	NULL
not	NULL
stimulate	NULL
transcription	NULL
from	NULL
a	NULL
non-octamer-containing	NULL
promoter	NULL
.	NULL

When	NULL
this	NULL
OTF-1	NULL
preparation	NULL
or	NULL
a	NULL
partially	NULL
purified	NULL
nuclear	NULL
fraction	NULL
containing	NULL
only	NULL
binding	NULL
activity	NULL
associated	NULL
with	NULL
OTF-2	NULL
is	NULL
added	NULL
to	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
,	NULL
very	NULL
little	NULL
stimulation	NULL
of	NULL
immunoglobulin	NULL
transcription	NULL
can	NULL
be	NULL
detected	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
although	NULL
octamer-binding	NULL
proteins	NULL
are	NULL
required	NULL
for	NULL
immuno-	NULL
Vor	NULL
.	NULL

10	NULL
,	NULL
1990	NULL
globulin	NULL
gene	NULL
transcription	NULL
,	NULL
they	NULL
are	NULL
not	NULL
sufficient	NULL
for	NULL
their	NULL
tissue-specific	NULL
expression	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
lines	NULL
.	NULL

SMS-SB	NULL
is	NULL
a	NULL
clonally	NULL
derived	NULL
human	NULL
pre-B-cell	NULL
line	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Nalm-6	NULL
is	NULL
also	NULL
a	NULL
human	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
pre-B-cell	NULL
line	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Both	NULL
lines	NULL
are	NULL
prototypically	NULL
pre-B	NULL
in	NULL
that	NULL
they	NULL
contain	NULL
no	NULL
light-chain	NULL
immunoglobulin	NULL
gene	NULL
rearrangements	NULL
(	NULL
P.	NULL
Fell	NULL
and	NULL
P.	NULL
Tucker	NULL
,	NULL
unpublished	NULL
results	NULL
)	NULL
.	NULL

Namalwa	NULL
is	NULL
an	NULL
African	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
line	NULL
;	NULL
HeLa	NULL
is	NULL
a	NULL
human	NULL
cervical	NULL
carcinoma	NULL
cell	NULL
line	NULL
.	NULL

BCL	NULL
,	NULL
is	NULL
a	NULL
spontaneously	NULL
derived	NULL
murine	NULL
B-cell	NULL
leukemia	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Namalwa	NULL
and	NULL
Nalm-6	NULL
were	NULL
propagated	NULL
in	NULL
vitro	NULL
in	NULL
RPMI	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
antibiotics	NULL
.	NULL

SMS-SB	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
serum-free	NULL
Iscones	NULL
modification	NULL
of	NULL
minimal	NULL
essential	NULL
medium	NULL
supplemented	NULL
with	NULL
insulin	NULL
(	NULL
10	NULL
pg/ml	NULL
)	NULL
,	NULL
transferrin	NULL
(	NULL
30	NULL
pug/m	NULL
!	NULL
)	NULL

,	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
10	NULL
g/m	NULL
!	NULL
)	NULL

,	NULL
and	NULL
ethanolamine	NULL
(	NULL
20	NULL
mM	NULL
)	NULL
(	NULL
52	NULL
)	NULL
.	NULL

Plasmids	NULL
,	NULL
probes	NULL
,	NULL
and	NULL
oligonucleotides	NULL
.	NULL

The	NULL
template	NULL
plasmid	NULL
for	NULL
the	NULL
in	NULL
vitro	NULL
transcription	NULL
assay	NULL
was	NULL
made	NULL
by	NULL
cloning	NULL
the	NULL
593-base-pair	NULL
(	NULL
bp	NULL
)	NULL
BamHI-Xbal	NULL
fragment	NULL
of	NULL
the	NULL
immunoglobulin	NULL
heavy-chain	NULL
gene	NULL
(	NULL
20	NULL
)	NULL
expressed	NULL
in	NULL
the	NULL
BCL	NULL
,	NULL
cell	NULL
line	NULL
into	NULL
pUC19	NULL
.	NULL

This	NULL
fragment	NULL
contains	NULL
270	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
,	NULL
including	NULL
the	NULL
conserved	NULL
heptamer	NULL
and	NULL
octamer	NULL
sequences	NULL
.	NULL

In	NULL
the	NULL
opposite	NULL
orienta-tion	NULL
,	NULL
a	NULL
420-bp	NULL
BamHI-Nrul	NULL
fragment	NULL
of	NULL
the	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
(	NULL
RSV	NULL
)	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
from	NULL
pRSVCAT	NULL
was	NULL
inserted	NULL
to	NULL
make	NULL
pBCL	NULL
,	NULL
RSV	NULL
.	NULL

Antisense	NULL
RNA	NULL
probes	NULL
were	NULL
made	NULL
by	NULL
cloning	NULL
DNA	NULL
fragments	NULL
into	NULL
the	NULL
pGEM4	NULL
vector	NULL
(	NULL
Promega	NULL
Biotec	NULL
,	NULL
Madison	NULL
,	NULL
Wis.	NULL
)	NULL
.	NULL

For	NULL
the	NULL
BCL	NULL
,	NULL
V	NULL
,	NULL
,	NULL
probe	NULL
,	NULL
a	NULL
322-bp	NULL
BamHI-Ncol	NULL
fragment	NULL
containing	NULL
55	NULL
bp	NULL
downstream	NULL
of	NULL
the	NULL
major	NULL
transcription	NULL
initiation	NULL
site	NULL
was	NULL
used	NULL
,	NULL
generating	NULL
pBCL	NULL
,	NULL
-5	NULL
'	NULL
.	NULL

This	NULL
plasmid	NULL
was	NULL
linearized	NULL
with	NULL
Hinfl	NULL
and	NULL
transcribed	NULL
with	NULL
SP6	NULL
polymerase	NULL
(	NULL
Promega	NULL
)	NULL
to	NULL
make	NULL
a	NULL
95-nucleotide-long	NULL
labeled	NULL
RNA	NULL
probe	NULL
.	NULL

For	NULL
the	NULL
RSV	NULL
probe	NULL
,	NULL
the	NULL
entire	NULL
420-bp	NULL
RSV	NULL
LTR	NULL
fragment	NULL
was	NULL
used	NULL
,	NULL
generating	NULL
pGEMRSV	NULL
.	NULL

This	NULL
plasmid	NULL
was	NULL
linearized	NULL
with	NULL
EcoRI	NULL
and	NULL
transcribed	NULL
with	NULL
T7	NULL
RNA	NULL
polymerase	NULL
to	NULL
make	NULL
a	NULL
113-nucle-otide-long	NULL
labeled	NULL
RNA	NULL
probe	NULL
.	NULL

Oligonucleotides	NULL
were	NULL
made	NULL
on	NULL
an	NULL
Applied	NULL
Biosystems	NULL
380A	NULL
oligonucleotide	NULL
synthesizer	NULL
.	NULL

The	NULL
double-stranded	NULL
octamer	NULL
oligonucleotide	NULL
contained	NULL
the	NULL
sequence	NULL
ATGAATATGCAAACAGGTG	NULL
and	NULL
its	NULL
complementary	NULL
strand	NULL
.	NULL

The	NULL
mutated	NULL
oligonucleotide	NULL
contained	NULL
the	NULL
sequence	NULL
GAATCACAGCAAATCATA	NULL
and	NULL
its	NULL
complementary	NULL
strand	NULL
.	NULL

ooo	NULL
Gel	NULL
migration	NULL
inhibition	NULL
assay	NULL
.	NULL

The	NULL
gel	NULL
migration	NULL
inhibition	NULL
assay	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
13	NULL
,	NULL
23	NULL
)	NULL
,	NULL
using	NULL
a	NULL
3'-end-labeled	NULL
322-bp	NULL
BamHI-Ncol	NULL
restriction	NULL
fragment	NULL
.	NULL

This	NULL
fragment	NULL
was	NULL
derived	NULL
from	NULL
plasmid	NULL
PMK3	NULL
(	NULL
13	NULL
,	NULL
23	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
heavy-chain	NULL
variable-region	NULL
gene	NULL
expressed	NULL
in	NULL
the	NULL
BCL	NULL
,	NULL
cell	NULL
line	NULL
.	NULL

Northern	NULL
(	NULL
RNA	NULL
)	NULL
blot	NULL
analysis	NULL
.	NULL

The	NULL
human	NULL
Cp	NULL
probe	NULL
used	NULL
in	NULL
Northern	NULL
blot	NULL
analysis	NULL
was	NULL
a	NULL
l-kilobase-pair	NULL
(	NULL
kb	NULL
)	NULL
Xbal	NULL
fragment	NULL
containing	NULL
portions	NULL
of	NULL
the	NULL
Cu2	NULL
and	NULL
Cp3	NULL
domains	NULL
(	NULL
50	NULL
)	NULL
.	NULL

The	NULL
oct-2	NULL
probe	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
L.	NULL
Staudt	NULL
and	NULL
consists	NULL
of	NULL
a	NULL
3.1-kb	NULL
cDNA	NULL
clone	NULL
(	NULL
21	NULL
)	NULL
.	NULL

The	NULL
B-actin	NULL
probe	NULL
was	NULL
a	NULL
700-bp	NULL
Pvull	NULL
fragment	NULL
from	NULL
a	NULL
human	NULL
cDNA	NULL
clone	NULL
.	NULL

RNA	NULL
was	NULL
isolated	NULL
by	NULL
the	NULL
guanidinium-hot	NULL
phenol	NULL
method	NULL
(	NULL
27	NULL
)	NULL
,	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
selected	NULL
on	NULL
poly	NULL
(	NULL
dT	NULL
)	NULL
;	NULL
,	NULL
;	NULL
;	NULL
(	NULL
Pharmacia	NULL
,	NULL
Inc.	NULL
,	NULL
Piscat-away	NULL
,	NULL
N.J.	NULL
)	NULL
,	NULL
and	NULL
separated	NULL
on	NULL
a	NULL
1	NULL
%	NULL
agarose-6	NULL
%	NULL
formaldehyde	NULL
gel	NULL
.	NULL

The	NULL
RNA	NULL
was	NULL
transferred	NULL
to	NULL
GeneScreen	NULL
(	NULL
Dupont	NULL
,	NULL
NEN	NULL
Research	NULL
Products	NULL
,	NULL
Boston	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

,	NULL
and	NULL
the	NULL
filter	NULL
was	NULL
prehybridized	NULL
at	NULL
42°C	NULL
for	NULL
4	NULL
h	NULL
in	NULL
50	NULL
%	NULL
formaldehyde-1	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
-1	NULL
M	NULL
sodium	NULL
chloride-10	NULL
%	NULL
TRANSCRIPTION	NULL
OF	NULL
IMMUNOGLOBULIN	NULL
GENES	NULL
983	NULL
dextran	NULL
.	NULL

The	NULL
labeled	NULL
probe	NULL
was	NULL
added	NULL
,	NULL
and	NULL
hybridization	NULL
was	NULL
continued	NULL
for	NULL
24	NULL
h	NULL
at	NULL
42°C	NULL
.	NULL

Hybridized	NULL
filters	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
2x	NULL
SSC	NULL
(	NULL
SSC	NULL
is	NULL
0.15	NULL
M	NULL
NaCl	NULL
plus	NULL
0.015	NULL
M	NULL
sodium	NULL
citrate	NULL
)	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
once	NULL
in	NULL
2	NULL
%	NULL
SSC-1	NULL
%	NULL
SDS	NULL
at	NULL
60°C	NULL
for	NULL
60	NULL
min	NULL
,	NULL
and	NULL
twice	NULL
in	NULL
0.01	NULL
%	NULL
SSC	NULL
.	NULL

After	NULL
autoradiography	NULL
,	NULL
filters	NULL
were	NULL
stripped	NULL
by	NULL
boiling	NULL
in	NULL
water	NULL
for	NULL
10	NULL
min	NULL
.	NULL

Purification	NULL
of	NULL
octamer-binding	NULL
proteins	NULL
from	NULL
nuclear	NULL
extracts	NULL
of	NULL
SMS-SB	NULL
and	NULL
HeLa	NULL
.	NULL

The	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Affinity-purified	NULL
octamer-binding	NULL
proteins	NULL
from	NULL
SMS-SB	NULL
and	NULL
HeLa	NULL
cells	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
13	NULL
)	NULL
,	NULL
with	NULL
modifications	NULL
.	NULL

Briefly	NULL
,	NULL
approximately	NULL
80	NULL
mg	NULL
of	NULL
nuclear	NULL
protein	NULL
derived	NULL
from	NULL
each	NULL
cell	NULL
line	NULL
was	NULL
passed	NULL
over	NULL
a	NULL
8-ml	NULL
DEAE	NULL
column	NULL
equilibrated	NULL
with	NULL
buffer	NULL
D.	NULL
The	NULL
octamer-binding	NULL
activity	NULL
flowed	NULL
through	NULL
the	NULL
column	NULL
under	NULL
these	NULL
conditions	NULL
and	NULL
was	NULL
subsequently	NULL
applied	NULL
to	NULL
a	NULL
4-ml	NULL
column	NULL
containing	NULL
heparin-agarose	NULL
(	NULL
Bethesda	NULL
Research	NULL
Laboratories	NULL
,	NULL
Inc.	NULL
,	NULL
Gaithersburg	NULL
,	NULL
Md	NULL
.	NULL
)	NULL

.	NULL

The	NULL
column	NULL
was	NULL
washed	NULL
,	NULL
and	NULL
the	NULL
bound	NULL
octamer-binding	NULL
proteins	NULL
were	NULL
eluted	NULL
with	NULL
2	NULL
column	NULL
volumes	NULL
of	NULL
buffer	NULL
D	NULL
containing	NULL
0.4	NULL
M	NULL
KCI	NULL
.	NULL

The	NULL
eluted	NULL
protein	NULL
was	NULL
precipitated	NULL
with	NULL
50	NULL
%	NULL
ammonium	NULL
sulfate	NULL
,	NULL
the	NULL
solubilized	NULL
pellet	NULL
was	NULL
applied	NULL
to	NULL
a	NULL
300-by-7.5-mm	NULL
Bio-Sil	NULL
TSK	NULL
250	NULL
column	NULL
,	NULL
and	NULL
fractions	NULL
containing	NULL
octamer-binding	NULL
activity	NULL
were	NULL
pooled	NULL
and	NULL
applied	NULL
to	NULL
a	NULL
sequence-specific	NULL
DNA	NULL
affinity	NULL
column	NULL
prepared	NULL
by	NULL
using	NULL
a	NULL
65-bp	NULL
S'-aminoethyl	NULL
oligonucleotide	NULL
attached	NULL
to	NULL
cyanogen-activated	NULL
Sephacryl	NULL
CL-2B-300	NULL
.	NULL

DNA-affinity	NULL
chromatography	NULL
was	NULL
performed	NULL
essentially	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
3	NULL
)	NULL
,	NULL
with	NULL
modifications	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
pooled	NULL
TSK-250	NULL
fractions	NULL
containing	NULL
octamer-binding	NULL
activity	NULL
were	NULL
equilibrated	NULL
to	NULL
0.25	NULL
M	NULL
KCl	NULL
in	NULL
buffer	NULL
D	NULL
,	NULL
and	NULL
heparin	NULL
sulfate	NULL
was	NULL
added	NULL
to	NULL
a	NULL
concentration	NULL
of	NULL
0.4	NULL
mg/ml	NULL
as	NULL
a	NULL
competitor	NULL
for	NULL
nonspecific	NULL
DNA-binding	NULL
proteins	NULL
.	NULL

The	NULL
mixture	NULL
was	NULL
allowed	NULL
to	NULL
stand	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
and	NULL
then	NULL
was	NULL
added	NULL
to	NULL
a	NULL
3-ml	NULL
DNA-affinity	NULL
column	NULL
.	NULL

The	NULL
bound	NULL
proteins	NULL
were	NULL
washed	NULL
with	NULL
at	NULL
least	NULL
5	NULL
column	NULL
volumes	NULL
of	NULL
buffer	NULL
D	NULL
containing	NULL
0.25	NULL
M	NULL
KCI	NULL
,	NULL
and	NULL
the	NULL
octamer-binding	NULL
activity	NULL
was	NULL
eluted	NULL
by	NULL
sequential	NULL
additions	NULL
of	NULL
buffer	NULL
D	NULL
containing	NULL
1	NULL
and	NULL
0.5	NULL
M	NULL
KCl	NULL
.	NULL

The	NULL
1	NULL
and	NULL
0.5	NULL
M	NULL
eluates	NULL
were	NULL
pooled	NULL
and	NULL
equilibrated	NULL
to	NULL
0.1	NULL
M	NULL
KCl	NULL
for	NULL
a	NULL
second	NULL
pass	NULL
over	NULL
a	NULL
1-ml	NULL
affinity	NULL
column	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
0.2	NULL
mg	NULL
of	NULL
heparin	NULL
per	NULL
ml	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
reactions	NULL
were	NULL
performed	NULL
essentially	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
5	NULL
)	NULL
,	NULL
with	NULL
some	NULL
modifications	NULL
.	NULL

After	NULL
isolation	NULL
of	NULL
crude	NULL
nuclei	NULL
,	NULL
the	NULL
pellets	NULL
were	NULL
suspended	NULL
in	NULL
buffer	NULL
C	NULL
at	NULL
a	NULL
1:1	NULL
volume	NULL
ratio	NULL
to	NULL
obtain	NULL
nuclear	NULL
extracts	NULL
with	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
approximately	NULL
10	NULL
mg/ml	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
dialyzed	NULL
twice	NULL
in	NULL
buffer	NULL
D	NULL
for	NULL
at	NULL
least	NULL
2	NULL
h	NULL
,	NULL
frozen	NULL
in	NULL
liquid	NULL
nitrogen	NULL
,	NULL
and	NULL
stored	NULL
at	NULL
-70°C	NULL
.	NULL

Reaction	NULL
mixtures	NULL
contained	NULL
12	NULL
mM	NULL
N-2-hydrox-yethylpiperazine-N'-2-ethanesulfonic	NULL
acid	NULL
(	NULL
HEPES	NULL
;	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
12	NULL
%	NULL
glycerol	NULL
,	NULL
60	NULL
mM	NULL
KCI	NULL
,	NULL
0.12	NULL
mM	NULL
EDTA	NULL
,	NULL
0.3	NULL
mM	NULL
dithio-threitol	NULL
,	NULL
0.3	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
12	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
600	NULL
LM	NULL
ATP	NULL
,	NULL
UTP	NULL
,	NULL
GTP	NULL
,	NULL
and	NULL
CTP	NULL
,	NULL
40	NULL
U	NULL
of	NULL
RNasin	NULL
(	NULL
Promega	NULL
)	NULL
,	NULL
1	NULL
wg	NULL
of	NULL
uncut	NULL
template	NULL
DNA	NULL
,	NULL
and	NULL
approximately	NULL
300	NULL
ug	NULL
of	NULL
nuclear	NULL
protein	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
50	NULL
wl	NULL
.	NULL

The	NULL
reaction	NULL
mixtures	NULL
were	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
30°C	NULL
.	NULL

The	NULL
protein	NULL
was	NULL
extracted	NULL
twice	NULL
with	NULL
phenol-chloroform	NULL
(	NULL
1:1	NULL
)	NULL
,	NULL
and	NULL
the	NULL
nucleic	NULL
acids	NULL
were	NULL
ethanol	NULL
precipitated	NULL
,	NULL
washed	NULL
with	NULL
70	NULL
%	NULL
ethanol	NULL
,	NULL
and	NULL
suspended	NULL
in	NULL
26	NULL
pl	NULL
of	NULL
water	NULL
.	NULL

The	NULL
DNA	NULL
was	NULL
digested	NULL
by	NULL
addition	NULL
of	NULL
3	NULL
pl	NULL
of	NULL
10x	NULL
DNase	NULL
buffer	NULL
(	NULL
400	NULL
mM	NULL
Tris	NULL
hydrochloride	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
100	NULL
mM	NULL
NaCl	NULL
,	NULL
60	NULL
mM	NULL
MgCl	NULL
;	NULL
,	NULL
)	NULL
and	NULL
1	NULL
U	NULL
of	NULL
RQ1	NULL
DNase	NULL
(	NULL
Promega	NULL
)	NULL
and	NULL
incubation	NULL
for	NULL
15	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

After	NULL
one	NULL
phenol-chloroform	NULL
extraction	NULL
,	NULL
the	NULL
RNA	NULL
was	NULL
ethanol	NULL
precipitated	NULL
.	NULL

RNase	NULL
protection	NULL
assay	NULL
.	NULL

In	NULL
vitro-generated	NULL
RNA	NULL
was	NULL
suspended	NULL
in	NULL
30	NULL
pl	NULL
of	NULL
hybridization	NULL
buffer	NULL
containing	NULL
80	NULL
%	NULL
984	NULL
JOHNSON	NULL
ET	NULL
AL	NULL
.	NULL

formamide	NULL
,	NULL
40	NULL
mM	NULL
piperazine-N	NULL
,	NULL
N'-bis	NULL
(	NULL
2-ethanesulfonic	NULL
acid	NULL
(	NULL
PIPES	NULL
;	NULL
pH	NULL
6.7	NULL
)	NULL
,	NULL
400	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
approximately	NULL
10°	NULL
cpm	NULL
of	NULL
antisense	NULL
RNA	NULL
probe	NULL
.	NULL

The	NULL
RNA	NULL
mixture	NULL
was	NULL
heated	NULL
to	NULL
90°C	NULL
for	NULL
2	NULL
min	NULL
and	NULL
placed	NULL
directly	NULL
at	NULL
60°C	NULL
overnight	NULL
.	NULL

After	NULL
hybridization	NULL
,	NULL
300	NULL
pl	NULL
of	NULL
digestion	NULL
buffer	NULL
containing	NULL
10	NULL
mM	NULL
Tris	NULL
hydrochloride	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
5	NULL
mM	NULL
EDTA	NULL
,	NULL
300	NULL
mM	NULL
NaCl	NULL
,	NULL
40	NULL
ug	NULL
of	NULL
RNase	NULL
A	NULL
(	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
,	NULL
St	NULL
,	NULL
Louis	NULL
,	NULL
Mo	NULL
.	NULL
)	NULL

per	NULL
ml	NULL
,	NULL
and	NULL
2,500	NULL
U	NULL
of	NULL
RNase	NULL
T	NULL
;	NULL
(	NULL
Bethesda	NULL
Research	NULL
Laboratories	NULL
)	NULL
was	NULL
added	NULL
,	NULL
and	NULL
digestion	NULL
was	NULL
continued	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
;	NULL
50	NULL
ug	NULL
of	NULL
proteinase	NULL
K	NULL
(	NULL
Sigma	NULL
)	NULL
and	NULL
SDS	NULL
(	NULL
0.6	NULL
%	NULL
,	NULL
final	NULL
concentration	NULL
)	NULL
was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
preparation	NULL
was	NULL
incubated	NULL
for	NULL
15	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

After	NULL
phenol-chloroform	NULL
extraction	NULL
,	NULL
RNA	NULL
was	NULL
ethanol	NULL
precipitated	NULL
and	NULL
suspended	NULL
in	NULL
80	NULL
%	NULL
formamide	NULL
and	NULL
dyes	NULL
.	NULL

Protected	NULL
RNA	NULL
fragments	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
6	NULL
%	NULL
acrylamide	NULL
gel	NULL
containing	NULL
50	NULL
%	NULL
urea	NULL
,	NULL
and	NULL
autoradiography	NULL
was	NULL
performed	NULL
for	NULL
12	NULL
to	NULL
48	NULL
h.	NULL
RESULTS	NULL
Some	NULL
pre-B-cell	NULL
lines	NULL
lack	NULL
OTF-2	NULL
.	NULL

Through	NULL
gel	NULL
retardation	NULL
assays	NULL
using	NULL
nuclear	NULL
extracts	NULL
made	NULL
from	NULL
a	NULL
variety	NULL
of	NULL
lymphoid	NULL
cell	NULL
lines	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
two	NULL
pre-B-cell	NULL
lines	NULL
,	NULL
SMS-SB	NULL
and	NULL
Nalm-6	NULL
,	NULL
that	NULL
express	NULL
very	NULL
low	NULL
levels	NULL
of	NULL
OTF-2	NULL
relative	NULL
to	NULL
a	NULL
phenotypically	NULL
more	NULL
mature	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
line	NULL
,	NULL
Namalwa	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

The	NULL
probe	NULL
used	NULL
in	NULL
this	NULL
assay	NULL
is	NULL
an	NULL
end-labeled	NULL
fragment	NULL
of	NULL
the	NULL
BCL	NULL
,	NULL
immunoglobulin	NULL
heavy-chain	NULL
gene	NULL
containing	NULL
the	NULL
conserved	NULL
octamer	NULL
and	NULL
heptamer	NULL
sequences	NULL
.	NULL

Species	NULL
1	NULL
(	NULL
S1	NULL
)	NULL
corresponds	NULL
to	NULL
a	NULL
protein	NULL
dimer	NULL
complex	NULL
formed	NULL
by	NULL
the	NULL
cooperative	NULL
binding	NULL
of	NULL
OTFs	NULL
to	NULL
both	NULL
the	NULL
octamer	NULL
and	NULL
the	NULL
heptamer	NULL
,	NULL
whereas	NULL
S2	NULL
and	NULL
S3	NULL
correspond	NULL
to	NULL
monomeric	NULL
OTF-1	NULL
and	NULL
OTF-2	NULL
,	NULL
respectively	NULL
(	NULL
18	NULL
,	NULL
24	NULL
,	NULL
34	NULL
,	NULL
35	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
a	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
octamer	NULL
sequence	NULL
,	NULL
but	NULL
not	NULL
one	NULL
containing	NULL
a	NULL
mutated	NULL
octamer	NULL
,	NULL
specifically	NULL
inhibited	NULL
the	NULL
formation	NULL
of	NULL
all	NULL
three	NULL
species	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lanes	NULL
3	NULL
,	NULL
4	NULL
,	NULL
6	NULL
,	NULL
7	NULL
,	NULL
9	NULL
,	NULL
10	NULL
,	NULL
12	NULL
,	NULL
and	NULL
13	NULL
)	NULL
.	NULL

A	NULL
nonspecific	NULL
band	NULL
(	NULL
NS	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
that	NULL
ran	NULL
closely	NULL
with	NULL
S3	NULL
was	NULL
seen	NULL
in	NULL
some	NULL
experiments	NULL
,	NULL
but	NULL
this	NULL
band	NULL
was	NULL
not	NULL
abolished	NULL
by	NULL
the	NULL
octamer-containing	NULL
oligonucleotide	NULL
.	NULL

The	NULL
underloading	NULL
of	NULL
Nalm-6	NULL
nuclear	NULL
protein	NULL
in	NULL
this	NULL
experiment	NULL
did	NULL
not	NULL
correlate	NULL
with	NULL
the	NULL
level	NULL
of	NULL
OTF-1	NULL
in	NULL
this	NULL
cell	NULL
line	NULL
,	NULL
which	NULL
was	NULL
approximately	NULL
the	NULL
same	NULL
as	NULL
the	NULL
levels	NULL
in	NULL
Namalwa	NULL
,	NULL
SMS-SB	NULL
,	NULL
and	NULL
HeLa	NULL
cells	NULL
.	NULL

The	NULL
level	NULL
of	NULL
OTF-2-binding	NULL
activity	NULL
in	NULL
these	NULL
pre-B-cell	NULL
lines	NULL
was	NULL
comparable	NULL
to	NULL
the	NULL
low	NULL
level	NULL
detectable	NULL
in	NULL
some	NULL
nonlymphoid	NULL
cell	NULL
lines	NULL
such	NULL
as	NULL
HeLa	NULL
,	NULL
yet	NULL
all	NULL
three	NULL
cell	NULL
lines	NULL
(	NULL
SMS-SB	NULL
,	NULL
Nalm-6	NULL
,	NULL
and	NULL
Namalwa	NULL
)	NULL
accumulated	NULL
similar	NULL
amounts	NULL
of	NULL
steady-state	NULL
immunoglobulin	NULL
heavy-chain	NULL
mRNA	NULL
in	NULL
vivo	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
when	NULL
normalized	NULL
to	NULL
B-actin	NULL
message	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
;	NULL
compare	NULL
lanes	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
3	NULL
)	NULL
.	NULL

Reprobing	NULL
the	NULL
blot	NULL
with	NULL
an	NULL
OTF-2-specific	NULL
probe	NULL
confirmed	NULL
that	NULL
the	NULL
level	NULL
of	NULL
OTF-2	NULL
mRNA	NULL
corresponded	NULL
to	NULL
the	NULL
amount	NULL
of	NULL
OTF-2-specific	NULL
binding	NULL
activity	NULL
in	NULL
each	NULL
cell	NULL
line	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Even	NULL
though	NULL
Namalwa	NULL
was	NULL
underloaded	NULL
and	NULL
SMS-SB	NULL
was	NULL
overloaded	NULL
(	NULL
when	NULL
normalized	NULL
to	NULL
B-actin	NULL
levels	NULL
in	NULL
Nalm-6	NULL
and	NULL
HeLa	NULL
cells	NULL
)	NULL
,	NULL
the	NULL
OTF-2-specific	NULL
,	NULL
7-kb	NULL
message	NULL
was	NULL
found	NULL
only	NULL
in	NULL
the	NULL
Namalwa	NULL
lane	NULL
.	NULL

This	NULL
finding	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
others	NULL
who	NULL
detected	NULL
this	NULL
message	NULL
only	NULL
in	NULL
cell	NULL
lines	NULL
containing	NULL
OTF-2-binding	NULL
activity	NULL
(	NULL
29	NULL
,	NULL
39	NULL
,	NULL
44	NULL
)	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
of	NULL
an	NULL
immunoglobulin	NULL
gene	NULL
does	NULL
not	NULL
correspond	NULL
to	NULL
OTF-2	NULL
expression	NULL
.	NULL

The	NULL
plasmid	NULL
used	NULL
as	NULL
a	NULL
template	NULL
in	NULL
the	NULL
in	NULL
vitro	NULL
transcription	NULL
assay	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
contains	NULL
the	NULL
expressed	NULL
V	NULL
,	NULL
,	NULL
promoter	NULL
from	NULL
the	NULL
BCL	NULL
,	NULL
cell	NULL
line	NULL
.	NULL

As	NULL
an	NULL
internal	NULL
control	NULL
,	NULL
the	NULL
RSV	NULL
LTR	NULL
was	NULL
inserted	NULL
into	NULL
the	NULL
template	NULL
plasmid	NULL
in	NULL
the	NULL
opposite	NULL
orientation	NULL
.	NULL

The	NULL
RSV	NULL
LTR	NULL
does	NULL
not	NULL
contain	NULL
a	NULL
consensus	NULL
octamer	NULL
motif	NULL
and	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
the	NULL
general	NULL
transcription	NULL
factor	NULL
C/EBP	NULL
(	NULL
38	NULL
)	NULL
and	NULL
to	NULL
be	NULL
active	NULL
in	NULL
both	NULL
lymphoid	NULL
and	NULL
nonlymphoid	NULL
cells	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

Bro	NULL
.	NULL

FIG	NULL
.	NULL

1	NULL
.	NULL

Gel	NULL
retardation	NULL
and	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
OTF-2	NULL
.	NULL

(	NULL
A	NULL
)	NULL
An	NULL
end-labeled	NULL
322-bp	NULL
fragment	NULL
from	NULL
the	NULL
BCL	NULL
,	NULL
heavy-chain	NULL
promoter	NULL
was	NULL
incubated	NULL
with	NULL
no	NULL
nuclear	NULL
extract	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
with	NULL
Namalwa	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
4	NULL
)	NULL
,	NULL
Nalm-6	NULL
(	NULL
lanes	NULL
5	NULL
to	NULL
7	NULL
)	NULL
,	NULL
SMS-SB	NULL
(	NULL
lanes	NULL
8	NULL
to	NULL
10	NULL
)	NULL
,	NULL
or	NULL
HeLa	NULL
(	NULL
lanes	NULL
10	NULL
to	NULL
13	NULL
)	NULL
nuclear	NULL
extract	NULL
.	NULL

Competitor	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
octamer	NULL
motif	NULL
(	NULL
0	NULL
;	NULL
lanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
9	NULL
,	NULL
and	NULL
12	NULL
)	NULL
or	NULL
a	NULL
mutated	NULL
octamer	NULL
motif	NULL
(	NULL
M	NULL
;	NULL
lanes	NULL
4	NULL
,	NULL
7	NULL
,	NULL
10	NULL
,	NULL
and	NULL
13	NULL
)	NULL
were	NULL
added	NULL
to	NULL
demonstrate	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
three	NULL
species	NULL
for	NULL
the	NULL
octamer	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
was	NULL
electrophoresed	NULL
on	NULL
a	NULL
1	NULL
%	NULL
agarose-formaldehyde	NULL
gel	NULL
and	NULL
transferred	NULL
to	NULL
GeneScreen	NULL
(	NULL
Dupont	NULL
,	NULL
NEN	NULL
)	NULL
.	NULL

The	NULL
same	NULL
blot	NULL
was	NULL
hybridized	NULL
with	NULL
a	NULL
,	NULL
constant-region	NULL
probe	NULL
(	NULL
Cm	NULL
)	NULL
,	NULL
stripped	NULL
and	NULL
hybridized	NULL
with	NULL
an	NULL
OTF-2	NULL
probe	NULL
,	NULL
stripped	NULL
again	NULL
,	NULL
and	NULL
hybridized	NULL
to	NULL
a	NULL
B-actin	NULL
probe	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
Namalwa	NULL
;	NULL
2	NULL
,	NULL
Nalm-6	NULL
;	NULL
3	NULL
,	NULL
SMS-SB	NULL
;	NULL
4	NULL
,	NULL
HeLa	NULL
.	NULL

NS	NULL
,	NULL
Nonspecific	NULL
band	NULL
.	NULL

The	NULL
antisense	NULL
RNA	NULL
probes	NULL
used	NULL
to	NULL
detect	NULL
the	NULL
in	NULL
vitro-generated	NULL
transcripts	NULL
span	NULL
the	NULL
transcription	NULL
initiation	NULL
start	NULL
sites	NULL
of	NULL
both	NULL
genes	NULL
and	NULL
are	NULL
shown	NULL
,	NULL
with	NULL
their	NULL
sizes	NULL
in	NULL
nucleotides	NULL
,	NULL
below	NULL
the	NULL
template	NULL
plasmid	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Also	NULL
shown	NULL
are	NULL
the	NULL
sizes	NULL
of	NULL
two	NULL
of	NULL
the	NULL
major	NULL
protected	NULL
fragments	NULL
that	NULL
were	NULL
formed	NULL
after	NULL
the	NULL
RNase	NULL
protection	NULL
assay	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

For	NULL
simplicity	NULL
,	NULL
only	NULL
two	NULL
of	NULL
the	NULL
four	NULL
major	NULL
start	NULL
sites	NULL
for	NULL
the	NULL
BCL	NULL
,	NULL
V	NULL
,	NULL
,	NULL
promoter	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

We	NULL
refer	NULL
only	NULL
to	NULL
RSV	NULL
species	NULL
that	NULL
migrated	NULL
between	NULL
55	NULL
and	NULL
64	NULL
bases	NULL
as	NULL
specific	NULL
,	NULL
since	NULL
bands	NULL
below	NULL
53	NULL
bases	NULL
also	NULL
appeared	NULL
in	NULL
unincubated	NULL
(	NULL
no	NULL
nucleoside	NULL
triphosphates	NULL
[	NULL
NTPs	NULL
)	NULL
)	NULL
controls	NULL
.	NULL

These	NULL
lower	NULL
bands	NULL
seen	NULL
with	NULL
the	NULL
RSV	NULL
probe	NULL
are	NULL
probably	NULL
due	NULL
to	NULL
self-hybridization	NULL
and	NULL
self-protec-tion	NULL
of	NULL
probe	NULL
sequences	NULL
,	NULL
since	NULL
the	NULL
probe	NULL
by	NULL
itself	NULL
also	NULL
gave	NULL
rise	NULL
to	NULL
these	NULL
bands	NULL
after	NULL
RNase	NULL
digestion	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
in	NULL
vitro	NULL
transcripts	NULL
were	NULL
shown	NULL
to	NULL
be	NULL
correctly	NULL
initiated	NULL
by	NULL
comparing	NULL
them	NULL
with	NULL
BCL	NULL
,	NULL
and	NULL
RSV	NULL
mRNA	NULL
made	NULL
in	NULL
vivo	NULL
,	NULL
which	NULL
also	NULL
contains	NULL
multiple	NULL
start	NULL
sites	NULL
.	NULL

Using	NULL
this	NULL
plasmid	NULL
,	NULL
we	NULL
show	NULL
that	NULL
nuclear	NULL
extracts	NULL
from	NULL
pre-B	NULL
cells	NULL
(	NULL
SMS-SB	NULL
and	NULL
Nalm-6	NULL
)	NULL
expressing	NULL
very	NULL
low	NULL
levels	NULL
of	NULL
OTF-2	NULL
could	NULL
transcribe	NULL
the	NULL
immunoglobulin	NULL
gene	NULL
as	NULL
well	NULL
as	NULL
or	NULL
better	NULL
than	NULL
nuclear	NULL
extract	NULL
from	NULL
a	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
TRANSCRIPTION	NULL
OF	NULL
IMMUNOGLOBULIN	NULL
GENES	NULL
985	NULL
BCL1	NULL
VH	NULL
Promoter	NULL
Hinfl	NULL
Ncol	NULL
Xbal	NULL
Vor	NULL
.	NULL

10	NULL
,	NULL
1990	NULL
RSV	NULL
Promoter	NULL
BamHI	NULL
EcoR	NULL
!	NULL

pBCL	NULL
1	NULL
RSVI	NULL
l	NULL
I	NULL
+63	NULL
=	NULL
+1	NULL
-50	NULL
PrODES	NULL
|	NULL
mnm	NULL
(	NULL
113	NULL
)	NULL
Protected	NULL
___	NULL
(	NULL
59	NULL
)	NULL
Fragments	NULL
(	NULL
63	NULL
)	NULL
~40	NULL
+1	NULL
+55	NULL
(	NULL
45	NULL
)	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Template	NULL
and	NULL
probes	NULL
used	NULL
in	NULL
the	NULL
in	NULL
vitro	NULL
transcription	NULL
reaction	NULL
and	NULL
RNase	NULL
protection	NULL
assay	NULL
.	NULL

A	NULL
593-bp	NULL
BamHI-Xbal	NULL
fragment	NULL
of	NULL
the	NULL
expressed	NULL
heavy-chain	NULL
immunoglobulin	NULL
gene	NULL
from	NULL
the	NULL
BCL	NULL
,	NULL
leukemia	NULL
cell	NULL
line	NULL
was	NULL
cloned	NULL
into	NULL
pUC19	NULL
.	NULL

In	NULL
the	NULL
opposite	NULL
orientation	NULL
a	NULL
420-bp	NULL
BamHI-Nrul	NULL
fragment	NULL
of	NULL
the	NULL
RSV	NULL
LTR	NULL
was	NULL
inserted	NULL
to	NULL
make	NULL
pBCL	NULL
,	NULL
RSV	NULL
.	NULL

Symbols	NULL
:	NULL
C	NULL
,	NULL
major	NULL
start	NULL
sites	NULL
of	NULL
transcription	NULL
:	NULL
@	NULL
.	NULL

conserved	NULL
heptamer	NULL
;	NULL
§	NULL
,	NULL
conserved	NULL
octamer	NULL
;	NULL
A	NULL
,	NULL
TATA	NULL
box	NULL
.	NULL

Antisense	NULL
RNA	NULL
probes	NULL
used	NULL
to	NULL
detect	NULL
the	NULL
in	NULL
vitro-generated	NULL
transcripts	NULL
span	NULL
the	NULL
initiation	NULL
start	NULL
site	NULL
of	NULL
each	NULL
gene	NULL
;	NULL
and	NULL
their	NULL
sizes	NULL
(	NULL
in	NULL
bases	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

The	NULL
protected	NULL
fragments	NULL
resulting	NULL
from	NULL
the	NULL
RNase	NULL
protection	NULL
assay	NULL
are	NULL
also	NULL
shown	NULL
,	NULL
with	NULL
sizes	NULL
(	NULL
in	NULL
bases	NULL
)	NULL
indicated	NULL
.	NULL

line	NULL
(	NULL
Namalwa	NULL
)	NULL
expressing	NULL
a	NULL
relatively	NULL
high	NULL
level	NULL
of	NULL
OTF-2	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
)	NULL
.	NULL

The	NULL
four	NULL
nuclear	NULL
extracts	NULL
in	NULL
this	NULL
experiment	NULL
contained	NULL
similar	NULL
levels	NULL
of	NULL
OTF-1l-binding	NULL
activity	NULL
per	NULL
milligram	NULL
of	NULL
protein	NULL
in	NULL
a	NULL
gel	NULL
retardation	NULL
assay	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Namalwa	NULL
nuclear	NULL
extract	NULL
also	NULL
contained	NULL
the	NULL
additional	NULL
binding	NULL
activity	NULL
associated	NULL
with	NULL
OTF-2	NULL
at	NULL
approximately	NULL
one-half	NULL
the	NULL
level	NULL
of	NULL
OTF-1	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
Namalwa	NULL
nuclear	NULL
extract	NULL
contained	NULL
high	NULL
levels	NULL
of	NULL
OTF-1	NULL
and	NULL
OTF-2	NULL
yet	NULL
was	NULL
no	NULL
more	NULL
transcriptionally	NULL
active	NULL
than	NULL
SMS-SB	NULL
or	NULL
Nalm-6	NULL
nuclear	NULL
extracts	NULL
argues	NULL
against	NULL
the	NULL
suggestion	NULL
(	NULL
25	NULL
)	NULL
that	NULL
differences	NULL
in	NULL
the	NULL
ability	NULL
of	NULL
various	NULL
cell	NULL
types	NULL
to	NULL
transcribe	NULL
immunoglobulin	NULL
genes	NULL
is	NULL
a	NULL
result	NULL
of	NULL
a	NULL
quantitative	NULL
difference	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
total	NULL
octamer-binding	NULL
protein	NULL
present	NULL
.	NULL

All	NULL
w	NULL
-	NULL
0	NULL
t	NULL
S	NULL
»	NULL
:	NULL
$	NULL
.	NULL

2	NULL
©	NULL
-B	NULL
&	NULL
1	NULL
£	NULL
&	NULL
v	NULL
Sei	NULL
y	NULL
'	NULL
3	NULL
``	NULL
6	NULL
0	NULL
'	NULL
>	NULL
40	NULL
o	NULL
0	NULL
ov	NULL
~	NULL
£	NULL
.v	NULL
o	NULL
;	NULL
+	NULL
z	NULL
ese	NULL
V	NULL
I	NULL
a	NULL
z	NULL
z	NULL
GI	NULL
23	NULL
«	NULL
4	NULL
1	NULL
:	NULL
>	NULL
23	NULL
.	NULL

``	NULL
@	NULL
t	NULL
b	NULL
~:6	NULL
7	NULL
.	NULL

>	NULL
:	NULL
08	NULL
:	NULL
9	NULL
=	NULL
10	NULL
p	NULL
7	NULL
«	NULL
Galr	NULL
Probe	NULL
--	NULL
it	NULL
-	NULL
RSV	NULL
Probe	NULL
--	NULL
A	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

RNase	NULL
protection	NULL
assay	NULL
of	NULL
transcripts	NULL
generated	NULL
in	NULL
vitro	NULL
.	NULL

In	NULL
vitro	NULL
transcripts	NULL
were	NULL
made	NULL
by	NULL
incubating	NULL
pBCL	NULL
,	NULL
RSV	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
with	NULL
nuclear	NULL
extracts	NULL
made	NULL
from	NULL
either	NULL
Namalwa	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
6	NULL
)	NULL
,	NULL
Nalm-6	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
7	NULL
)	NULL
,	NULL
SMS-SB	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
8	NULL
)	NULL
,	NULL
or	NULL
HeLa	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
9	NULL
)	NULL
cells	NULL
.	NULL

TPs	NULL
were	NULL
excluded	NULL
,	NULL
and	NULL
reactions	NULL
were	NULL
kept	NULL
on	NULL
ice	NULL
in	NULL
lanes	NULL
5	NULL
and	NULL
10	NULL
as	NULL
a	NULL
control	NULL
for	NULL
nonspecific	NULL
bands	NULL
.	NULL

Transcripts	NULL
were	NULL
detected	NULL
by	NULL
using	NULL
either	NULL
the	NULL
BCL	NULL
,	NULL
V	NULL
;	NULL
,	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
5	NULL
)	NULL
or	NULL
RSV	NULL
(	NULL
lanes	NULL
6	NULL
to	NULL
10	NULL
)	NULL
antisense	NULL
RNA	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

These	NULL
in	NULL
vitro	NULL
transcripts	NULL
were	NULL
shown	NULL
to	NULL
have	NULL
authentic	NULL
start	NULL
sites	NULL
by	NULL
comparing	NULL
them	NULL
with	NULL
BCL	NULL
,	NULL
cellular	NULL
RNA	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lane	NULL
10	NULL
)	NULL
.	NULL

As	NULL
a	NULL
molecular	NULL
size	NULL
marker	NULL
,	NULL
an	NULL
A+G	NULL
reaction	NULL
was	NULL
done	NULL
on	NULL
an	NULL
end-labeled	NULL
,	NULL
322-bp	NULL
fragment	NULL
from	NULL
the	NULL
BCL	NULL
,	NULL
gene	NULL
(	NULL
lane	NULL
11	NULL
)	NULL
;	NULL
sizes	NULL
(	NULL
in	NULL
nucleotides	NULL
)	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
right	NULL
.	NULL

cell	NULL
lines	NULL
tested	NULL
transcribe	NULL
from	NULL
the	NULL
control	NULL
RSV	NULL
promoter	NULL
with	NULL
approximately	NULL
equal	NULL
efficiency	NULL
,	NULL
whereas	NULL
transcription	NULL
from	NULL
the	NULL
immunoglobulin	NULL
promoter	NULL
is	NULL
specific	NULL
for	NULL
only	NULL
lymphoid	NULL
cell	NULL
nuclear	NULL
extract	NULL
.	NULL

These	NULL
results	NULL
support	NULL
our	NULL
in	NULL
vivo	NULL
data	NULL
and	NULL
confirm	NULL
that	NULL
the	NULL
level	NULL
of	NULL
OTF-2	NULL
in	NULL
lymphoid	NULL
cells	NULL
does	NULL
not	NULL
correspond	NULL
to	NULL
the	NULL
ability	NULL
of	NULL
these	NULL
cells	NULL
to	NULL
transcribe	NULL
immunoglobulin	NULL
heavy-chain	NULL
genes	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
of	NULL
immunoglobulin	NULL
genes	NULL
is	NULL
dependent	NULL
on	NULL
octamer-binding	NULL
proteins	NULL
.	NULL

Through	NULL
mutational	NULL
analysis	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
an	NULL
intact	NULL
octamer	NULL
is	NULL
necessary	NULL
for	NULL
immunoglobulin	NULL
promoter	NULL
activity	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
(	NULL
8	NULL
,	NULL
12	NULL
,	NULL
28	NULL
,	NULL
41	NULL
)	NULL
.	NULL

It	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
through	NULL
transfection	NULL
experiments	NULL
that	NULL
an	NULL
octamer	NULL
element	NULL
placed	NULL
upstream	NULL
of	NULL
a	NULL
heterologous	NULL
gene	NULL
can	NULL
confer	NULL
lymphoid	NULL
specificity	NULL
(	NULL
6	NULL
,	NULL
51	NULL
)	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
octamer-binding	NULL
proteins	NULL
are	NULL
required	NULL
for	NULL
the	NULL
lymphoid-specific	NULL
immunoglobulin	NULL
gene	NULL
expression	NULL
seen	NULL
in	NULL
our	NULL
in	NULL
vitro	NULL
assay	NULL
,	NULL
in	NULL
vitro	NULL
transcription	NULL
competition	NULL
experiments	NULL
were	NULL
performed	NULL
.	NULL

Addition	NULL
of	NULL
a	NULL
duplex	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
octamer	NULL
sequence	NULL
to	NULL
the	NULL
in	NULL
vitro	NULL
transcription	NULL
reaction	NULL
specifically	NULL
inhibited	NULL
transcription	NULL
of	NULL
the	NULL
immunoglobulin	NULL
gene	NULL
,	NULL
whereas	NULL
addition	NULL
of	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
mutated	NULL
octamer	NULL
did	NULL
not	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
)	NULL
.	NULL

This	NULL
inhibition	NULL
occurred	NULL
when	NULL
either	NULL
Namalwa	NULL
,	NULL
SMS-SB	NULL
,	NULL
or	NULL
Nalm-6	NULL
nuclear	NULL
extract	NULL
was	NULL
used	NULL
.	NULL

Even	NULL
the	NULL
small	NULL
amount	NULL
of	NULL
transcription	NULL
seen	NULL
in	NULL
some	NULL
experiments	NULL
by	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
was	NULL
inhibited	NULL
by	NULL
octamer-containing	NULL
oligonucleotides	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
oligonucleotide	NULL
needed	NULL
to	NULL
inhibit	NULL
transcription	NULL
roughly	NULL
correlated	NULL
with	NULL
the	NULL
amount	NULL
needed	NULL
to	NULL
inhibit	NULL
binding	NULL
in	NULL
a	NULL
gel	NULL
retardation	NULL
assay	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

This	NULL
inhibition	NULL
was	NULL
specific	NULL
for	NULL
the	NULL
immunoglobulin	NULL
gene	NULL
,	NULL
since	NULL
transcription	NULL
of	NULL
the	NULL
RSV	NULL
LTR	NULL
by	NULL
any	NULL
of	NULL
the	NULL
nuclear	NULL
extracts	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
addition	NULL
of	NULL
either	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
OTF-1	NULL
,	NULL
in	NULL
the	NULL
pre-B	NULL
cells	NULL
lacking	NULL
OTF-2	NULL
,	NULL
functions	NULL
through	NULL
direct	NULL
octamer	NULL
binding	NULL
to	NULL
transactivate	NULL
immunoglobulin	NULL
gene	NULL
transcription	NULL
in	NULL
vitro	NULL
.	NULL

Addition	NULL
of	NULL
highly	NULL
enriched	NULL
OTF-1	NULL
to	NULL
lymphoid	NULL
nuclear	NULL
extracts	NULL
stimulates	NULL
immunoglobulin	NULL
gene	NULL
transcription	NULL
.	NULL

To	NULL
test	NULL
more	NULL
directly	NULL
whether	NULL
OTF-1	NULL
can	NULL
function	NULL
to	NULL
transactivate	NULL
immunoglobulin	NULL
genes	NULL
,	NULL
a	NULL
highly	NULL
purified	NULL
preparation	NULL
of	NULL
OTF-1	NULL
,	NULL
devoid	NULL
of	NULL
OTF-2	NULL
activity	NULL
,	NULL
was	NULL
added	NULL
to	NULL
the	NULL
in	NULL
vitro	NULL
transcription	NULL
reaction	NULL
.	NULL

OTF-1	NULL
was	NULL
purified	NULL
from	NULL
both	NULL
HeLa	NULL
and	NULL
SMS-SB	NULL
cells	NULL
through	NULL
a	NULL
series	NULL
of	NULL
chromatography	NULL
steps	NULL
,	NULL
including	NULL
two	NULL
passages	NULL
over	NULL
an	NULL
octamer-affinity	NULL
resin	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
12	NULL
;	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

OTF-1	NULL
preparations	NULL
from	NULL
either	NULL
cell	NULL
line	NULL
appeared	NULL
identical	NULL
and	NULL
986	NULL
JOHNSON	NULL
ET	NULL
AL	NULL
.	NULL

Oligo	NULL
&	NULL
<	NULL
i	NULL
:	NULL
D	NULL
O	NULL
|	NULL
%	NULL
&	NULL
#	NULL
--	NULL
Vm	NULL
--	NULL
t	NULL
FR	NULL
C	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

Bro	NULL
.	NULL

BCL	NULL
,	NULL
;	NULL
RNA	NULL
i	NULL
%	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Competition	NULL
of	NULL
in	NULL
vitro	NULL
transcription	NULL
by	NULL
an	NULL
octamer-containing	NULL
duplex	NULL
oligonucleotide	NULL
.	NULL

(	NULL
A	NULL
)	NULL
In	NULL
vitro	NULL
transcription	NULL
reactions	NULL
were	NULL
done	NULL
by	NULL
incubating	NULL
pBCL	NULL
,	NULL
RSV	NULL
with	NULL
SMS-SB	NULL
nuclear	NULL
extract	NULL
.	NULL

Transcripts	NULL
were	NULL
detected	NULL
by	NULL
using	NULL
either	NULL
the	NULL
BCL	NULL
,	NULL
V	NULL
,	NULL
;	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
)	NULL
or	NULL
RSV	NULL
(	NULL
lanes	NULL
4	NULL
to	NULL
6	NULL
)	NULL
antisense	NULL
RNA	NULL
probe	NULL
.	NULL

No	NULL
oligonucleotide	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
4	NULL
)	NULL
or	NULL
1	NULL
ug	NULL
of	NULL
duplexed	NULL
oligonucleotide	NULL
(	NULL
20-mer	NULL
)	NULL
containing	NULL
either	NULL
the	NULL
octamer	NULL
(	NULL
0	NULL
;	NULL
lanes	NULL
2	NULL
and	NULL
5	NULL
)	NULL
or	NULL
a	NULL
mutated	NULL
form	NULL
of	NULL
the	NULL
octamer	NULL
(	NULL
M	NULL
;	NULL
lanes	NULL
3	NULL
and	NULL
6	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
in	NULL
vitro	NULL
transcription	NULL
reaction	NULL
.	NULL

An	NULL
A+G	NULL
reaction	NULL
was	NULL
done	NULL
as	NULL
a	NULL
molecular	NULL
size	NULL
marker	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
In	NULL
vitro	NULL
transcription	NULL
reactions	NULL
were	NULL
done	NULL
using	NULL
Namalwa	NULL
nuclear	NULL
extract	NULL
and	NULL
pBCL	NULL
,	NULL
RSV	NULL
.	NULL

All	NULL
transcripts	NULL
were	NULL
detected	NULL
by	NULL
using	NULL
the	NULL
BCL	NULL
,	NULL
V	NULL
,	NULL
,	NULL
probe	NULL
.	NULL

No	NULL
oligonucleotide	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
or	NULL
increasing	NULL
amounts	NULL
of	NULL
either	NULL
the	NULL
octamer-containing	NULL
oligonucleotide	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
4	NULL
)	NULL
or	NULL
the	NULL
mutated	NULL
octamer-containing	NULL
oligonucleotide	NULL
(	NULL
lanes	NULL
6	NULL
to	NULL
9	NULL
)	NULL
were	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
.	NULL

Total	NULL
RNA	NULL
(	NULL
4	NULL
pg	NULL
)	NULL
isolated	NULL
from	NULL
BCL	NULL
,	NULL
cells	NULL
was	NULL
used	NULL
in	NULL
the	NULL
RNase	NULL
protection	NULL
assay	NULL
to	NULL
demonstrate	NULL
that	NULL
in	NULL
vitro-generated	NULL
transcripts	NULL
were	NULL
correctly	NULL
initiated	NULL
(	NULL
lane	NULL
10	NULL
)	NULL
.	NULL

An	NULL
A+G	NULL
reaction	NULL
was	NULL
done	NULL
as	NULL
a	NULL
molecular	NULL
size	NULL
marker	NULL
(	NULL
lane	NULL
11	NULL
)	NULL
;	NULL
sizes	NULL
(	NULL
in	NULL
nucleotides	NULL
)	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
right	NULL
.	NULL

contained	NULL
three	NULL
visible	NULL
bands	NULL
on	NULL
a	NULL
silver-stained	NULL
SDS-poly-acrylamide	NULL
gel	NULL
with	NULL
apparent	NULL
molecular	NULL
weights	NULL
of	NULL
100	NULL
,	NULL
92	NULL
,	NULL
and	NULL
70	NULL
kilodaltons	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

Partial	NULL
amino	NULL
acid	NULL
sequence	NULL
analysis	NULL
of	NULL
both	NULL
the	NULL
92-	NULL
and	NULL
70-kilodalton	NULL
proteins	NULL
confirmed	NULL
that	NULL
neither	NULL
shared	NULL
detectable	NULL
homology	NULL
with	NULL
cloned	NULL
OTF-1	NULL
or	NULL
OTF-2	NULL
(	NULL
L.	NULL
Carayannopoulos	NULL
et	NULL
al	NULL
.	NULL

,	NULL
manuscript	NULL
in	NULL
prepa-ration	NULL
)	NULL
.	NULL

At	NULL
least	NULL
one	NULL
of	NULL
these	NULL
proteins	NULL
,	NULL
presumably	NULL
the	NULL
100-kilodalton	NULL
protein	NULL
by	NULL
virtue	NULL
of	NULL
its	NULL
size	NULL
relatedness	NULL
with	NULL
cloned	NULL
OTF-1	NULL
,	NULL
gave	NULL
rise	NULL
to	NULL
S1	NULL
and	NULL
S2	NULL
,	NULL
shown	NULL
by	NULL
others	NULL
to	NULL
contain	NULL
monomeric	NULL
and	NULL
dimeric	NULL
OTF-1	NULL
,	NULL
respectively	NULL
(	NULL
18	NULL
,	NULL
34	NULL
,	NULL
35	NULL
)	NULL
.	NULL

When	NULL
these	NULL
OTF-1	NULL
preparations	NULL
from	NULL
either	NULL
SMS-SB	NULL
or	NULL
HeLa	NULL
cells	NULL
were	NULL
added	NULL
to	NULL
SMS-SB	NULL
nuclear	NULL
extract	NULL
,	NULL
a	NULL
stimulation	NULL
of	NULL
immunoglobulin	NULL
gene	NULL
transcription	NULL
occurred	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
and	NULL
5C	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

When	NULL
normalized	NULL
to	NULL
binding	NULL
activity	NULL
,	NULL
HeLa	NULL
OTF-1	NULL
and	NULL
SMS-SB	NULL
OTF-1	NULL
gave	NULL
approximately	NULL
equal	NULL
stimulatory	NULL
activity	NULL
,	NULL
suggesting	NULL
that	NULL
OTF-1	NULL
from	NULL
lymphoid	NULL
cells	NULL
is	NULL
the	NULL
same	NULL
as	NULL
OTF-1	NULL
from	NULL
nonlymphoid	NULL
cells	NULL
.	NULL

This	NULL
transactivation	NULL
was	NULL
specific	NULL
for	NULL
the	NULL
immunoglobulin	NULL
gene	NULL
,	NULL
since	NULL
addition	NULL
of	NULL
OTF-1	NULL
had	NULL
little	NULL
effect	NULL
on	NULL
RSV	NULL
LTR	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
)	NULL
.	NULL

However	NULL
,	NULL
when	NULL
these	NULL
OTF-1	NULL
preparations	NULL
were	NULL
added	NULL
to	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
,	NULL
immunoglobulin	NULL
gene	NULL
transcription	NULL
did	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
stimulated	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lanes	NULL
5	NULL
to	NULL
7	NULL
)	NULL
.	NULL

The	NULL
diffuse	NULL
spots	NULL
seen	NULL
in	NULL
the	NULL
HeLa	NULL
lanes	NULL
were	NULL
not	NULL
specific	NULL
transcripts	NULL
,	NULL
since	NULL
these	NULL
also	NULL
could	NULL
be	NULL
seen	NULL
in	NULL
the	NULL
unincubated	NULL
(	NULL
no	NULL
NTPs	NULL
)	NULL
control	NULL
.	NULL

We	NULL
believe	NULL
these	NULL
spots	NULL
are	NULL
due	NULL
to	NULL
excess	NULL
tRNA	NULL
used	NULL
as	NULL
carrier	NULL
in	NULL
the	NULL
assay	NULL
,	NULL
since	NULL
when	NULL
the	NULL
tRNA	NULL
amount	NULL
was	NULL
reduced	NULL
or	NULL
when	NULL
glycogen	NULL
was	NULL
used	NULL
as	NULL
a	NULL
carrier	NULL
,	NULL
the	NULL
spots	NULL
were	NULL
not	NULL
seen	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
these	NULL
spots	NULL
may	NULL
be	NULL
masking	NULL
specific	NULL
transcripts	NULL
of	NULL
higher	NULL
molecular	NULL
weight	NULL
,	NULL
but	NULL
it	NULL
is	NULL
clear	NULL
that	NULL
the	NULL
smaller	NULL
transcripts	NULL
were	NULL
not	NULL
stimulated	NULL
by	NULL
OTF-1	NULL
addition	NULL
.	NULL

Since	NULL
we	NULL
have	NULL
never	NULL
observed	NULL
transcription	NULL
from	NULL
some	NULL
of	NULL
the	NULL
start	NULL
sites	NULL
but	NULL
not	NULL
from	NULL
the	NULL
others	NULL
,	NULL
we	NULL
feel	NULL
that	NULL
immunoglobulin	NULL
transcription	NULL
is	NULL
not	NULL
stimulated	NULL
in	NULL
this	NULL
case	NULL
.	NULL

This	NULL
result	NULL
differs	NULL
from	NULL
a	NULL
previous	NULL
report	NULL
in	NULL
which	NULL
addition	NULL
of	NULL
OTF-1	NULL
to	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
did	NULL
stimulate	NULL
immunoglobu-	NULL
lin	NULL
gene	NULL
transcription	NULL
(	NULL
25	NULL
)	NULL
.	NULL

These	NULL
data	NULL
,	NULL
using	NULL
highly	NULL
purified	NULL
OTF-1	NULL
,	NULL
extend	NULL
the	NULL
experiment	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
indicating	NULL
that	NULL
OTF-1	NULL
can	NULL
function	NULL
to	NULL
transactivate	NULL
an	NULL
immunoglobulin	NULL
gene	NULL
in	NULL
lymphoid	NULL
nuclear	NULL
extracts	NULL
but	NULL
functions	NULL
very	NULL
poorly	NULL
if	NULL
at	NULL
all	NULL
in	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
.	NULL

This	NULL
finding	NULL
suggests	NULL
a	NULL
qualitative	NULL
difference	NULL
between	NULL
B	NULL
cells	NULL
and	NULL
nonlymphoid	NULL
cells	NULL
which	NULL
allows	NULL
OTF-1	NULL
to	NULL
efficiently	NULL
transactivate	NULL
immunoglobulin	NULL
genes	NULL
only	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
B	NULL
lineage	NULL
.	NULL

OTF-1	NULL
and	NULL
OTF-2	NULL
appear	NULL
to	NULL
have	NULL
approximately	NULL
equal	NULL
stimulatory	NULL
ability	NULL
.	NULL

With	NULL
the	NULL
finding	NULL
that	NULL
OTF-1	NULL
could	NULL
transactivate	NULL
immunoglobulin	NULL
gene	NULL
transcription	NULL
,	NULL
it	NULL
was	NULL
of	NULL
interest	NULL
to	NULL
compare	NULL
the	NULL
stimulatory	NULL
ability	NULL
of	NULL
OTF-1	NULL
versus	NULL
OTF-2	NULL
.	NULL

Size-separated	NULL
protein	NULL
fractions	NULL
containing	NULL
either	NULL
OTF-1	NULL
or	NULL
OTF-2	NULL
were	NULL
made	NULL
from	NULL
BCL	NULL
,	NULL
nuclear	NULL
extract	NULL
.	NULL

Since	NULL
OTF-1	NULL
and	NULL
OTF-2	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
have	NULL
very	NULL
similar	NULL
DNA-binding	NULL
affinities	NULL
(	NULL
40	NULL
)	NULL
,	NULL
these	NULL
fractions	NULL
were	NULL
normalized	NULL
for	NULL
binding	NULL
activity	NULL
in	NULL
a	NULL
gel	NULL
retardation	NULL
assay	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
and	NULL
added	NULL
to	NULL
the	NULL
in	NULL
vitro	NULL
transcription	NULL
system	NULL
.	NULL

Both	NULL
fractions	NULL
appeared	NULL
to	NULL
have	NULL
similar	NULL
trans-activating	NULL
ability	NULL
when	NULL
added	NULL
to	NULL
a	NULL
B-cell	NULL
nuclear	NULL
extract	NULL
,	NULL
but	NULL
again	NULL
when	NULL
either	NULL
fraction	NULL
was	NULL
added	NULL
to	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
,	NULL
very	NULL
little	NULL
stimulation	NULL
occurred	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
lanes	NULL
7	NULL
to	NULL
10	NULL
)	NULL
.	NULL

Maximum	NULL
activity	NULL
was	NULL
seen	NULL
with	NULL
5	NULL
pl	NULL
of	NULL
either	NULL
the	NULL
OTF-1	NULL
(	NULL
4	NULL
mg	NULL
)	NULL
-	NULL
or	NULL
OTF-2	NULL
(	NULL
2.5	NULL
pmg	NULL
)	NULL
-containing	NULL
fraction	NULL
with	NULL
the	NULL
B-cell	NULL
extract	NULL
.	NULL

Increasing	NULL
the	NULL
amount	NULL
of	NULL
OTF	NULL
in	NULL
the	NULL
reaction	NULL
resulted	NULL
in	NULL
a	NULL
decrease	NULL
in	NULL
transcription	NULL
of	NULL
the	NULL
immunoglobulin	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
;	NULL
compare	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
and	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

This	NULL
inhibition	NULL
of	NULL
transcription	NULL
with	NULL
excess	NULL
OTF	NULL
has	NULL
also	NULL
been	NULL
noticed	NULL
by	NULL
others	NULL
using	NULL
different	NULL
systems	NULL
(	NULL
19	NULL
,	NULL
25	NULL
)	NULL
.	NULL

Yet	NULL
even	NULL
at	NULL
these	NULL
excess	NULL
levels	NULL
of	NULL
OTF-1	NULL
and	NULL
OTF-2	NULL
,	NULL
immunoglobulin	NULL
gene	NULL
transcription	NULL
was	NULL
not	NULL
significantly	NULL
stimulated	NULL
when	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
was	NULL
used	NULL
.	NULL

This	NULL
finding	NULL
differs	NULL
from	NULL
another	NULL
report	NULL
(	NULL
29	NULL
)	NULL
in	NULL
which	NULL
a	NULL
cloned	NULL
cDNA	NULL
of	NULL
a	NULL
lymphoid-specific	NULL
octamer-binding	NULL
protein	NULL
,	NULL
presumably	NULL
OTF-2	NULL
,	NULL
was	NULL
able	NULL
to	NULL
activate	NULL
transcription	NULL
of	NULL
a	NULL
B-cell-specific	NULL
promoter	NULL
in	NULL
HeLa	NULL
cells	NULL
in	NULL
cotransfection	NULL
experiments	NULL
.	NULL

The	NULL
artificial	NULL
Vor	NULL
.	NULL

10	NULL
,	NULL
1990	NULL
A	NULL
$	NULL
3	NULL
3	NULL
a-	NULL
Wwe	NULL
$	NULL
2	NULL
__	NULL
s-	NULL
mmo	NULL
~	NULL
&	NULL
&	NULL
B	NULL
_	NULL
Extract	NULL
5	NULL
5	NULL
CTF~MFLQ	NULL
-	NULL
4	NULL
2	NULL
-	NULL
4	NULL
2	NULL
t	NULL
U	NULL
C	NULL
#	NULL
»	NULL
E	NULL
£2	NULL
z	NULL
Z	NULL
Extract	NULL
+sms-sB4	NULL
2+-sms-s84	NULL
2	NULL
1	NULL
2	NULL
~	NULL
``	NULL
~	NULL
1	NULL
3	NULL
-neg-	NULL
-	NULL
>	NULL
«	NULL
<	NULL
l	NULL
«	NULL
ge	NULL
*	NULL
e	NULL
&	NULL
e	NULL
a	NULL
*	NULL
122-3	NULL
4	NULL
.	NULL

5-6	NULL
T.	NULL
*B	NULL
i-V	NULL
,	NULL
,	NULL
Probe-iIt-RSV	NULL
Probe	NULL
-A	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Addition	NULL
of	NULL
affinity-purified	NULL
OTF-1	NULL
preparations	NULL
to	NULL
in	NULL
vitro	NULL
transcription	NULL
reactions	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Silver-stained	NULL
7.5	NULL
%	NULL
SDS-poly-acrylamide	NULL
gel	NULL
of	NULL
purified	NULL
OTF-1	NULL
preparations	NULL
from	NULL
SMS-SB	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
and	NULL
HeLa	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
cells	NULL
.	NULL

Lane	NULL
1	NULL
contains	NULL
a	NULL
low-molecular-size	NULL
marker	NULL
mix	NULL
(	NULL
Pharmacia	NULL
)	NULL
,	NULL
with	NULL
the	NULL
sizes	NULL
of	NULL
phosphorylase	NULL
B	NULL
(	NULL
94	NULL
kDa	NULL
)	NULL
and	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
67	NULL
kDa	NULL
)	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
In	NULL
vitro	NULL
transcription	NULL
reactions	NULL
were	NULL
performed	NULL
by	NULL
using	NULL
pBCL	NULL
,	NULL
RSV	NULL
as	NULL
the	NULL
template	NULL
and	NULL
reduced	NULL
amounts	NULL
of	NULL
nuclear	NULL
extract	NULL
(	NULL
approximately	NULL
200	NULL
ug	NULL
of	NULL
nuclear	NULL
protein	NULL
)	NULL
from	NULL
either	NULL
SMS-SB	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
and	NULL
8	NULL
to	NULL
10	NULL
)	NULL
or	NULL
HeLa	NULL
(	NULL
lanes	NULL
4	NULL
to	NULL
6	NULL
and	NULL
11	NULL
to	NULL
13	NULL
)	NULL
cells	NULL
.	NULL

No	NULL
OTF-1	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
4	NULL
,	NULL
8	NULL
,	NULL
and	NULL
11	NULL
)	NULL
or	NULL
1	NULL
pl	NULL
(	NULL
55	NULL
ng	NULL
)	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
5	NULL
,	NULL
9	NULL
,	NULL
and	NULL
12	NULL
)	NULL
or	NULL
2	NULL
pl	NULL
(	NULL
110	NULL
ng	NULL
)	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
10	NULL
,	NULL
and	NULL
13	NULL
)	NULL
of	NULL
partially	NULL
purified	NULL
OTF-1	NULL
from	NULL
SMS-SB	NULL
cells	NULL
was	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
(	NULL
55	NULL
ng	NULL
of	NULL
OTF-1	NULL
preparation	NULL
contains	NULL
approximately	NULL
the	NULL
same	NULL
amount	NULL
of	NULL
octamer-binding	NULL
activity	NULL
as	NULL
25	NULL
pg	NULL
of	NULL
crude	NULL
nuclear	NULL
extract	NULL
in	NULL
a	NULL
gel	NULL
retardation	NULL
assay	NULL
)	NULL
.	NULL

No	NULL
NTPs	NULL
were	NULL
added	NULL
,	NULL
and	NULL
reactions	NULL
were	NULL
kept	NULL
on	NULL
ice	NULL
in	NULL
lanes	NULL
7	NULL
and	NULL
14	NULL
as	NULL
a	NULL
control	NULL
for	NULL
nonspecific	NULL
bands	NULL
.	NULL

In	NULL
vitro	NULL
transcripts	NULL
were	NULL
detected	NULL
by	NULL
using	NULL
either	NULL
the	NULL
BCL	NULL
;	NULL
V	NULL
;	NULL
;	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
7	NULL
)	NULL
or	NULL
RSV	NULL
(	NULL
lanes	NULL
8	NULL
to	NULL
14	NULL
)	NULL
antisense	NULL
RNA	NULL
probe	NULL
.	NULL

An	NULL
A+G	NULL
reaction	NULL
was	NULL
done	NULL
as	NULL
a	NULL
molecular	NULL
size	NULL
marker	NULL
(	NULL
lane	NULL
15	NULL
)	NULL
;	NULL
sizes	NULL
(	NULL
in	NULL
nucleotides	NULL
)	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
right	NULL
.	NULL

(	NULL
C	NULL
)	NULL
No	NULL
OTF-1	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
5	NULL
)	NULL
or	NULL
1	NULL
jl	NULL
(	NULL
55	NULL
ng	NULL
)	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
6	NULL
)	NULL
or	NULL
2	NULL
pl	NULL
(	NULL
110	NULL
ng	NULL
)	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
7	NULL
)	NULL
of	NULL
partially	NULL
purified	NULL
OTF-1	NULL
from	NULL
HeLa	NULL
cells	NULL
was	NULL
added	NULL
to	NULL
in	NULL
vitro	NULL
transcription	NULL
reactions	NULL
containing	NULL
pBCL	NULL
,	NULL
RSV	NULL
and	NULL
SMS-SB	NULL
nuclear	NULL
extract	NULL
.	NULL

No	NULL
NTPs	NULL
were	NULL
added	NULL
,	NULL
and	NULL
reactions	NULL
were	NULL
kept	NULL
on	NULL
ice	NULL
in	NULL
lanes	NULL
4	NULL
and	NULL
8	NULL
as	NULL
a	NULL
control	NULL
.	NULL

In	NULL
vitro	NULL
transcripts	NULL
were	NULL
detected	NULL
by	NULL
using	NULL
either	NULL
the	NULL
BCL	NULL
,	NULL
V	NULL
;	NULL
,	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
4	NULL
)	NULL
or	NULL
RSV	NULL
(	NULL
lanes	NULL
5	NULL
to	NULL
8	NULL
)	NULL
antisense	NULL
RNA	NULL
probe	NULL
.	NULL

Arrows	NULL
indicate	NULL
specific	NULL
protected	NULL
fragments	NULL
.	NULL

TRANSCRIPTION	NULL
OF	NULL
IMMUNOGLOBULIN	NULL
GENES	NULL
987	NULL
A	NULL
.	NULL

1-2	NULL
``	NULL
9	NULL
S1	NULL
-	NULL
»	NULL
S2	NULL
.	NULL

-*	NULL
S3	NULL
-	NULL
»	NULL
-	NULL
-	NULL
OAM	NULL
B	NULL
.	NULL

<	NULL
I	NULL
bz	NULL
Extract	NULL
-	NULL
i	NULL
--	NULL
-SMS	NULL
-SB	NULL
--	NULL
«	NULL
OTF-1	NULL
-_	NULL
§	NULL
40	NULL
-	NULL
_.-	NULL
.	NULL

-	NULL
$	NULL
AQ	NULL
.-	NULL
_-	NULL
d	NULL
OTF-2	NULL
-	NULL
-	NULL
-	NULL
§	NULL
40	NULL
-_-	NULL
_-	NULL
5	NULL
10	NULL
.	NULL

®	NULL
s	NULL
.	NULL

-	NULL
@	NULL
*	NULL
#	NULL
=	NULL
&	NULL
t	NULL
'	NULL
.o	NULL
.	NULL

A	NULL
.	NULL

5	NULL
6	NULL
_	NULL
-7..	NULL
B6	NULL
.	NULL

9	NULL
.	NULL

10	NULL
11	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Analysis	NULL
of	NULL
size-separated	NULL
nuclear	NULL
protein	NULL
fractions	NULL
containing	NULL
either	NULL
OTF-1	NULL
or	NULL
OTF-2	NULL
by	NULL
binding	NULL
and	NULL
in	NULL
vitro	NULL
transcription	NULL
stimulation	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Gel	NULL
retardation	NULL
assay	NULL
of	NULL
size-separated	NULL
protein	NULL
fractions	NULL
from	NULL
BCL	NULL
,	NULL
nuclear	NULL
extract	NULL
,	NULL
using	NULL
an	NULL
end-labeled	NULL
,	NULL
322-bp	NULL
immunoglobulin	NULL
heavy-chain	NULL
promoter	NULL
fragment	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
5	NULL
pl	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
of	NULL
crude	NULL
BCL	NULL
,	NULL
nuclear	NULL
extract	NULL
;	NULL
2	NULL
,	NULL
5	NULL
pul	NULL
(	NULL
4	NULL
ug	NULL
)	NULL
of	NULL
OTF-l-containing	NULL
nuclear	NULL
protein	NULL
fraction	NULL
;	NULL
3	NULL
,	NULL
5	NULL
pl	NULL
(	NULL
2.5	NULL
ug	NULL
)	NULL
of	NULL
OTF-2	NULL
?	NULL

-containing	NULL
nuclear	NULL
protein	NULL
fraction	NULL
.	NULL

(	NULL
B	NULL
)	NULL
In	NULL
vitro	NULL
transcription	NULL
reactions	NULL
were	NULL
done	NULL
by	NULL
using	NULL
pBCL	NULL
,	NULL
RSV	NULL
as	NULL
the	NULL
template	NULL
and	NULL
either	NULL
SMS-SB	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
5	NULL
)	NULL
or	NULL
HeLa	NULL
(	NULL
lanes	NULL
6	NULL
to	NULL
10	NULL
)	NULL
nuclear	NULL
extract	NULL
.	NULL

The	NULL
BCL	NULL
,	NULL
V	NULL
;	NULL
;	NULL
probe	NULL
was	NULL
used	NULL
to	NULL
detect	NULL
transcripts	NULL
in	NULL
all	NULL
lanes	NULL
.	NULL

OTF-containing	NULL
fractions	NULL
were	NULL
added	NULL
to	NULL
each	NULL
reaction	NULL
as	NULL
indicated	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
and	NULL
6	NULL
,	NULL
no	NULL
OTF	NULL
;	NULL
2	NULL
and	NULL
7	NULL
,	NULL
5	NULL
pl	NULL
(	NULL
4	NULL
mg	NULL
)	NULL
of	NULL
OTF-l-containing	NULL
fraction	NULL
;	NULL
3	NULL
and	NULL
8	NULL
,	NULL
10	NULL
pl	NULL
(	NULL
8	NULL
ug	NULL
)	NULL
of	NULL
OTF-1-containing	NULL
fraction	NULL
;	NULL
4	NULL
and	NULL
9	NULL
,	NULL
5	NULL
ul	NULL
(	NULL
2.5	NULL
mg	NULL
)	NULL
of	NULL
OTF-2-containing	NULL
fraction	NULL
;	NULL
5	NULL
and	NULL
10	NULL
,	NULL
10	NULL
pl	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
of	NULL
OTF-2-containing	NULL
fraction	NULL
.	NULL

Total	NULL
RNA	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
from	NULL
BCL	NULL
,	NULL
cells	NULL
was	NULL
used	NULL
in	NULL
the	NULL
RNase	NULL
protection	NULL
assay	NULL
to	NULL
indicate	NULL
correctly	NULL
initiated	NULL
transcripts	NULL
(	NULL
lane	NULL
11	NULL
)	NULL
.	NULL

promoter	NULL
construct	NULL
used	NULL
in	NULL
the	NULL
experiments	NULL
of	NULL
Miiller	NULL
et	NULL
al	NULL
.	NULL

(	NULL
29	NULL
)	NULL
did	NULL
not	NULL
contain	NULL
the	NULL
conserved	NULL
heptamer	NULL
(	NULL
7	NULL
,	NULL
24	NULL
)	NULL
found	NULL
in	NULL
all	NULL
immunoglobulin	NULL
heavy-chain	NULL
genes	NULL
,	NULL
and	NULL
the	NULL
distance	NULL
between	NULL
the	NULL
octamer	NULL
and	NULL
the	NULL
B-globin	NULL
TATA	NULL
box	NULL
which	NULL
was	NULL
used	NULL
was	NULL
different	NULL
from	NULL
that	NULL
found	NULL
in	NULL
immunoglobulin	NULL
genes	NULL
.	NULL

These	NULL
factors	NULL
may	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
apparent	NULL
differences	NULL
in	NULL
results	NULL
,	NULL
we	NULL
used	NULL
a	NULL
fragment	NULL
of	NULL
an	NULL
actual	NULL
heavy-chain	NULL
gene	NULL
containing	NULL
both	NULL
the	NULL
octamer	NULL
,	NULL
heptamer	NULL
,	NULL
and	NULL
possibly	NULL
important	NULL
flanking	NULL
sequences	NULL
in	NULL
wild-type	NULL
spatial	NULL
arrange-ment	NULL
.	NULL

We	NULL
conclude	NULL
from	NULL
these	NULL
experiments	NULL
that	NULL
OTF-1	NULL
and	NULL
OTF-2	NULL
appear	NULL
to	NULL
have	NULL
equal	NULL
transactivation	NULL
ability	NULL
when	NULL
normalized	NULL
for	NULL
binding	NULL
activity	NULL
.	NULL

Furthermore	NULL
,	NULL
our	NULL
finding	NULL
that	NULL
addition	NULL
of	NULL
OTF-2	NULL
to	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
is	NULL
not	NULL
sufficient	NULL
for	NULL
immunoglobulin	NULL
gene	NULL
transcription	NULL
supports	NULL
our	NULL
previous	NULL
finding	NULL
that	NULL
OTF-2	NULL
alone	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
regulate	NULL
immunoglobulin	NULL
tissue	NULL
specificity	NULL
,	NULL
at	NULL
least	NULL
at	NULL
the	NULL
level	NULL
of	NULL
the	NULL
promoter	NULL
.	NULL

988	NULL
JOHNSON	NULL
ET	NULL
AL	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
examined	NULL
the	NULL
relationship	NULL
between	NULL
the	NULL
level	NULL
of	NULL
OTF-2	NULL
in	NULL
a	NULL
cell	NULL
and	NULL
its	NULL
ability	NULL
to	NULL
express	NULL
immunoglobulin	NULL
genes	NULL
.	NULL

We	NULL
report	NULL
the	NULL
finding	NULL
of	NULL
two	NULL
pre-B-cell	NULL
lines	NULL
that	NULL
contain	NULL
very	NULL
low	NULL
levels	NULL
of	NULL
OTF-2	NULL
,	NULL
as	NULL
judged	NULL
by	NULL
DNA-binding	NULL
activity	NULL
,	NULL
yet	NULL
still	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
u	NULL
heavy-chain	NULL
mRNA	NULL
.	NULL

Despite	NULL
the	NULL
small	NULL
sample	NULL
size	NULL
,	NULL
these	NULL
examples	NULL
suggest	NULL
that	NULL
immunoglobulin	NULL
gene	NULL
transcription	NULL
can	NULL
precede	NULL
the	NULL
appearance	NULL
of	NULL
detectable	NULL
OTF-2	NULL
mRNA	NULL
or	NULL
binding	NULL
activity	NULL
during	NULL
B-cell	NULL
development	NULL
.	NULL

This	NULL
finding	NULL
,	NULL
besides	NULL
indicating	NULL
that	NULL
OTF-1	NULL
in	NULL
at	NULL
least	NULL
some	NULL
pre-B	NULL
cells	NULL
is	NULL
sufficient	NULL
to	NULL
transactivate	NULL
immunoglobulin	NULL
gene	NULL
transcription	NULL
in	NULL
vivo	NULL
,	NULL
also	NULL
suggests	NULL
that	NULL
octamer-binding	NULL
proteins	NULL
alone	NULL
do	NULL
not	NULL
regulate	NULL
the	NULL
tissue-specific	NULL
activation	NULL
of	NULL
heavy-chain	NULL
immunoglobulin	NULL
gene	NULL
expression	NULL
.	NULL

If	NULL
the	NULL
presence	NULL
of	NULL
OTF-2	NULL
or	NULL
the	NULL
quantity	NULL
of	NULL
total	NULL
OTF	NULL
activity	NULL
is	NULL
not	NULL
sufficient	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
immunoglobulin	NULL
gene	NULL
expression	NULL
as	NULL
our	NULL
results	NULL
suggest	NULL
,	NULL
there	NULL
remains	NULL
the	NULL
question	NULL
of	NULL
what	NULL
regulates	NULL
the	NULL
B-cell	NULL
specificity	NULL
of	NULL
immunoglobulin	NULL
promoters	NULL
.	NULL

One	NULL
possibility	NULL
is	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
inhibitor	NULL
found	NULL
in	NULL
all	NULL
cells	NULL
not	NULL
of	NULL
the	NULL
B	NULL
lineage	NULL
.	NULL

Evidence	NULL
for	NULL
a	NULL
negative	NULL
regulator	NULL
(	NULL
s	NULL
)	NULL
in	NULL
non-B	NULL
cells	NULL
has	NULL
been	NULL
provided	NULL
by	NULL
cell	NULL
fusion	NULL
experiments	NULL
in	NULL
which	NULL
immunoglobulin-producing	NULL
myeloma	NULL
cells	NULL
were	NULL
fused	NULL
with	NULL
either	NULL
T	NULL
cells	NULL
or	NULL
fibroblasts	NULL
(	NULL
17	NULL
,	NULL
53	NULL
)	NULL
.	NULL

The	NULL
immunoglobulin	NULL
heavy-chain	NULL
gene	NULL
enhancer	NULL
as	NULL
well	NULL
as	NULL
the	NULL
immunoglobulin	NULL
kappa	NULL
and	NULL
heavy-chain	NULL
gene	NULL
promoters	NULL
were	NULL
all	NULL
found	NULL
to	NULL
be	NULL
targets	NULL
of	NULL
suppression	NULL
after	NULL
cell	NULL
fusion	NULL
.	NULL

However	NULL
,	NULL
when	NULL
we	NULL
mixed	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
with	NULL
B	NULL
or	NULL
pre-B	NULL
nuclear	NULL
extract	NULL
,	NULL
no	NULL
inhibition	NULL
of	NULL
in	NULL
vitro	NULL
transcription	NULL
was	NULL
found	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
finding	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
those	NULL
of	NULL
others	NULL
(	NULL
25	NULL
)	NULL
and	NULL
argues	NULL
against	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
preexisting	NULL
dominant	NULL
repressor	NULL
in	NULL
nonlymphoid	NULL
cell	NULL
nuclear	NULL
extract	NULL
which	NULL
acts	NULL
directly	NULL
on	NULL
immunoglobulin	NULL
promoters	NULL
.	NULL

Another	NULL
possibility	NULL
is	NULL
that	NULL
an	NULL
additional	NULL
positive	NULL
regulatory	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
found	NULL
only	NULL
in	NULL
B	NULL
cells	NULL
is	NULL
required	NULL
for	NULL
efficient	NULL
expression	NULL
of	NULL
immunoglobulin	NULL
genes	NULL
.	NULL

This	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
would	NULL
likely	NULL
be	NULL
non-DNA	NULL
binding	NULL
or	NULL
weakly	NULL
DNA	NULL
binding	NULL
and	NULL
exert	NULL
its	NULL
activity	NULL
primarily	NULL
through	NULL
protein-protein	NULL
interac-tions	NULL
.	NULL

An	NULL
example	NULL
of	NULL
just	NULL
such	NULL
a	NULL
protein	NULL
is	NULL
Vmw65	NULL
,	NULL
a	NULL
virion	NULL
component	NULL
of	NULL
herpes	NULL
simplex	NULL
virus	NULL
responsible	NULL
for	NULL
the	NULL
transcriptional	NULL
transactivation	NULL
of	NULL
viral	NULL
immediate-early	NULL
genes	NULL
.	NULL

A	NULL
cis-acting	NULL
sequence	NULL
,	NULL
TAATGARAT	NULL
(	NULL
R	NULL
=	NULL
purine	NULL
)	NULL
,	NULL
is	NULL
found	NULL
at	NULL
least	NULL
once	NULL
in	NULL
all	NULL
of	NULL
these	NULL
immediate-early	NULL
gene	NULL
promoters	NULL
and	NULL
is	NULL
required	NULL
for	NULL
Vmw65	NULL
transactivation	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Vmw65	NULL
,	NULL
however	NULL
,	NULL
does	NULL
not	NULL
bind	NULL
DNA	NULL
directly	NULL
and	NULL
has	NULL
recently	NULL
been	NULL
shown	NULL
to	NULL
require	NULL
complex	NULL
formation	NULL
with	NULL
an	NULL
octamer-binding	NULL
protein	NULL
very	NULL
similar	NULL
to	NULL
,	NULL
if	NULL
not	NULL
identical	NULL
with	NULL
,	NULL
OTF-1	NULL
in	NULL
order	NULL
to	NULL
exert	NULL
its	NULL
activity	NULL
(	NULL
11	NULL
,	NULL
19	NULL
,	NULL
30	NULL
,	NULL
31	NULL
,	NULL
36	NULL
,	NULL
49	NULL
)	NULL
.	NULL

The	NULL
octamer-binding	NULL
protein	NULL
binds	NULL
the	NULL
TAATGARAT	NULL
sequence	NULL
but	NULL
can	NULL
not	NULL
transactivate	NULL
these	NULL
promoters	NULL
without	NULL
the	NULL
presence	NULL
of	NULL
Vmw65	NULL
.	NULL

Additional	NULL
flanking	NULL
sequences	NULL
,	NULL
besides	NULL
the	NULL
core	NULL
octamer-binding	NULL
site	NULL
,	NULL
are	NULL
also	NULL
needed	NULL
for	NULL
OTF-Vmw65	NULL
complex	NULL
formation	NULL
and	NULL
transactivation	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
a	NULL
Vmw65-like	NULL
protein	NULL
in	NULL
B	NULL
cells	NULL
which	NULL
interacts	NULL
with	NULL
OTF-1	NULL
and	NULL
OTF-2	NULL
as	NULL
well	NULL
as	NULL
important	NULL
flanking	NULL
sequences	NULL
found	NULL
in	NULL
immunoglobulin	NULL
promoters	NULL
could	NULL
explain	NULL
our	NULL
results	NULL
.	NULL

Other	NULL
regulatory	NULL
factors	NULL
associating	NULL
with	NULL
OTFs	NULL
could	NULL
also	NULL
explain	NULL
the	NULL
additional	NULL
wide	NULL
range	NULL
of	NULL
activities	NULL
such	NULL
as	NULL
cell	NULL
cycle	NULL
regulation	NULL
of	NULL
the	NULL
histone	NULL
H2b	NULL
gene	NULL
or	NULL
adenovirus	NULL
DNA	NULL
replication	NULL
requiring	NULL
an	NULL
intact	NULL
octamer	NULL
sequence	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
document	NULL
that	NULL
the	NULL
level	NULL
of	NULL
OTF-2	NULL
in	NULL
lymphoid	NULL
cells	NULL
does	NULL
not	NULL
correspond	NULL
to	NULL
the	NULL
ability	NULL
of	NULL
these	NULL
cells	NULL
to	NULL
express	NULL
immunoglobulin	NULL
genes	NULL
in	NULL
vivo	NULL
or	NULL
in	NULL
vitro	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
find	NULL
that	NULL
addition	NULL
of	NULL
a	NULL
highly	NULL
enriched	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

preparation	NULL
of	NULL
OTF-1	NULL
to	NULL
B	NULL
or	NULL
pre-B	NULL
nuclear	NULL
extract	NULL
specifically	NULL
stimulates	NULL
immunoglobulin	NULL
gene	NULL
expression	NULL
in	NULL
an	NULL
in	NULL
vitro	NULL
transcription	NULL
assay	NULL
.	NULL

The	NULL
discrepancy	NULL
between	NULL
our	NULL
results	NULL
and	NULL
those	NULL
of	NULL
others	NULL
(	NULL
25	NULL
)	NULL
on	NULL
the	NULL
activity	NULL
of	NULL
OTFs	NULL
when	NULL
added	NULL
to	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
is	NULL
difficult	NULL
to	NULL
explain	NULL
.	NULL

One	NULL
possibility	NULL
is	NULL
the	NULL
difference	NULL
in	NULL
promoters	NULL
used	NULL
in	NULL
each	NULL
study	NULL
.	NULL

Whereas	NULL
we	NULL
used	NULL
a	NULL
DNA	NULL
fragment	NULL
from	NULL
the	NULL
BCL	NULL
,	NULL
heavy-chain	NULL
gene	NULL
containing	NULL
270	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
,	NULL
including	NULL
both	NULL
the	NULL
conserved	NULL
heptamer	NULL
and	NULL
octamer	NULL
,	NULL
LeBowitz	NULL
et	NULL
al	NULL
.	NULL

(	NULL
25	NULL
)	NULL
used	NULL
a	NULL
promoter	NULL
construct	NULL
containing	NULL
only	NULL
69	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
initiation	NULL
site	NULL
,	NULL
including	NULL
only	NULL
the	NULL
octamer	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
heptamer	NULL
or	NULL
other	NULL
upstream	NULL
flanking	NULL
sequences	NULL
could	NULL
be	NULL
important	NULL
in	NULL
preventing	NULL
immunoglobulin	NULL
transcription	NULL
by	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
when	NULL
exogenous	NULL
OTF	NULL
is	NULL
added	NULL
.	NULL

Small	NULL
differences	NULL
in	NULL
the	NULL
in	NULL
vitro	NULL
transcription	NULL
reaction	NULL
conditions	NULL
such	NULL
as	NULL
the	NULL
presence	NULL
of	NULL
polyvinyl	NULL
alcohol	NULL
or	NULL
creatine	NULL
phosphate	NULL
used	NULL
by	NULL
LeBowitz	NULL
et	NULL
al	NULL
.	NULL

might	NULL
also	NULL
account	NULL
for	NULL
differences	NULL
in	NULL
results	NULL
.	NULL

Finally	NULL
,	NULL
differences	NULL
in	NULL
OTF	NULL
activity	NULL
could	NULL
be	NULL
due	NULL
to	NULL
the	NULL
different	NULL
method	NULL
by	NULL
which	NULL
OTFs	NULL
were	NULL
purified	NULL
and	NULL
the	NULL
degree	NULL
of	NULL
purity	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
our	NULL
OTF-1	NULL
preparations	NULL
from	NULL
either	NULL
HeLa	NULL
or	NULL
SMS-SB	NULL
cells	NULL
appear	NULL
identical	NULL
in	NULL
both	NULL
protein	NULL
content	NULL
and	NULL
transactivational	NULL
ability	NULL
argues	NULL
that	NULL
OTF-1	NULL
in	NULL
pre-B	NULL
cells	NULL
is	NULL
the	NULL
same	NULL
as	NULL
OTF-1	NULL
in	NULL
nonlymphoid	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
we	NULL
do	NULL
not	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
there	NULL
may	NULL
be	NULL
a	NULL
family	NULL
of	NULL
OTF-1	NULL
proteins	NULL
that	NULL
have	NULL
different	NULL
activities	NULL
when	NULL
the	NULL
octamer	NULL
motif	NULL
is	NULL
in	NULL
different	NULL
contexts	NULL
.	NULL

Whatever	NULL
the	NULL
explanation	NULL
for	NULL
differences	NULL
in	NULL
previous	NULL
results	NULL
,	NULL
our	NULL
findings	NULL
using	NULL
this	NULL
in	NULL
vitro	NULL
transcription	NULL
system	NULL
and	NULL
highly	NULL
purified	NULL
OTF-1	NULL
agree	NULL
more	NULL
closely	NULL
with	NULL
what	NULL
is	NULL
actually	NULL
seen	NULL
in	NULL
vivo	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
Lydia	NULL
Nanu	NULL
and	NULL
Patricia	NULL
A.	NULL
S.	NULL
Wheeler	NULL
for	NULL
the	NULL
growing	NULL
and	NULL
harvesting	NULL
of	NULL
SMS-SB	NULL
cells	NULL
and	NULL
Maureen	NULL
Willard	NULL
,	NULL
Chhaya	NULL
Das	NULL
,	NULL
Caroline	NULL
Humphries	NULL
,	NULL
and	NULL
Teresa	NULL
Eversole	NULL
for	NULL
technical	NULL
assistance	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Cindy	NULL
Baselski	NULL
and	NULL
Marilyn	NULL
Gardner	NULL
for	NULL
typing	NULL
and	NULL
proofreading	NULL
the	NULL
manuscript	NULL
.	NULL

We	NULL
especially	NULL
thank	NULL
L.	NULL
Staudt	NULL
for	NULL
his	NULL
gift	NULL
of	NULL
the	NULL
OTF-2	NULL
probe	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Public	NULL
Health	NULL
Service	NULL
grants	NULL
Al-180186	NULL
to	NULL
P.W.T	NULL
.	NULL

,	NULL
Al-18499	NULL
to	NULL
J.	NULL
D.C.	NULL
,	NULL
and	NULL
GM-31689	NULL
to	NULL
J.	NULL
D.C.	NULL
and	NULL
P.W.T	NULL
.	NULL

from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
.	NULL

J.	NULL
H.H	NULL
.	NULL

was	NULL
a	NULL
fellow	NULL
of	NULL
the	NULL
Leukemia	NULL
Society	NULL
of	NULL
America	NULL
.	NULL

LITERATURE	NULL
CITED	NULL
1	NULL
.	NULL

Ares	NULL
,	NULL
M.	NULL
,	NULL
Jr.	NULL
,	NULL
M.	NULL
Mangin	NULL
,	NULL
and	NULL
A.	NULL
M.	NULL
Weiner	NULL
.	NULL

1985	NULL
.	NULL

Orientation-dependent	NULL
transcriptional	NULL
activator	NULL
upstream	NULL
of	NULL
a	NULL
human	NULL
U2	NULL
snRNA	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

5:1560-1570	NULL
.	NULL

2	NULL
.	NULL

Bodner	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
Castrillo	NULL
,	NULL
L.	NULL
E.	NULL
Theill	NULL
,	NULL
T.	NULL
Deerinck	NULL
,	NULL
M.	NULL
Ellisman	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
pituitary-specific	NULL
transcription	NULL
factor	NULL
GHF-1	NULL
is	NULL
a	NULL
homeobox-containing	NULL
protein	NULL
.	NULL

Cell	NULL
55:505-518	NULL
.	NULL

3	NULL
.	NULL

Briggs	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
J.	NULL
T.	NULL
Kadonaga	NULL
,	NULL
S.	NULL
P.	NULL
Bell	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1986	NULL
.	NULL

Purification	NULL
and	NULL
biochemical	NULL
characterization	NULL
of	NULL
the	NULL
promoter-specific	NULL
transcription	NULL
factor	NULL
,	NULL
Spl	NULL
.	NULL

Science	NULL
234:47-52	NULL
.	NULL

4	NULL
.	NULL

Clerc	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
L.	NULL
M.	NULL
Corcoran	NULL
,	NULL
J.	NULL
H.	NULL
LeBowitz	NULL
,	NULL
D.	NULL
Baltimore	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
B-cell-specific	NULL
Octo-2	NULL
protein	NULL
contains	NULL
POU	NULL
box-	NULL
and	NULL
homeo	NULL
box-type	NULL
domains	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

2:1570-1581	NULL
.	NULL

5	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
R.	NULL
M.	NULL
Lebovitz	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1983	NULL
.	NULL

Accurate	NULL
transcription	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11:1475-1489	NULL
.	NULL

6	NULL
.	NULL

Dreyfus	NULL
,	NULL
M.	NULL
,	NULL
N.	NULL
Doyen	NULL
,	NULL
and	NULL
F.	NULL
Rougeon	NULL
.	NULL

1987	NULL
.	NULL

The	NULL
conserved	NULL
decanucleotide	NULL
from	NULL
the	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
promoter	NULL
induces	NULL
a	NULL
very	NULL
high	NULL
transcriptional	NULL
activity	NULL
in	NULL
B-cells	NULL
when	NULL
introduced	NULL
into	NULL
an	NULL
heterologous	NULL
promoter	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

6:1685-1690	NULL
.	NULL

7	NULL
.	NULL

Eaton	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
K.	NULL
Calame	NULL
.	NULL

1987	NULL
.	NULL

Multiple	NULL
DNA	NULL
sequence	NULL
elements	NULL
are	NULL
necessary	NULL
for	NULL
the	NULL
function	NULL
of	NULL
an	NULL
immunoglobulin	NULL
Vor	NULL
.	NULL

10	NULL
,	NULL
1990	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25.	NULL
heavy	NULL
chain	NULL
promoter	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84:7634-7638.	NULL
.	NULL

Falkner	NULL
,	NULL
F.	NULL
G.	NULL
,	NULL
and	NULL
H.	NULL
G.	NULL
Zachau	NULL
.	NULL

1984	NULL
.	NULL

Correct	NULL
transcription	NULL
of	NULL
an	NULL
immunoglobulin	NULL
K	NULL
gene	NULL
requires	NULL
an	NULL
upstream	NULL
fragment	NULL
containing	NULL
conserved	NULL
sequence	NULL
elements	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
310	NULL
:	NULL
71-74.	NULL
.	NULL

Finney	NULL
,	NULL
M.	NULL
,	NULL
G.	NULL
Ruvkun	NULL
,	NULL
and	NULL
H.	NULL
R.	NULL
Horvitz	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
C.	NULL
elegans	NULL
cell	NULL
lineage	NULL
and	NULL
differentiation	NULL
gene	NULL
unc-86	NULL
encodes	NULL
a	NULL
protein	NULL
with	NULL
a	NULL
homeodomain	NULL
and	NULL
extended	NULL
similarity	NULL
to	NULL
transcription	NULL
factors	NULL
.	NULL

Cell	NULL
55:757-769	NULL
.	NULL

Flether	NULL
,	NULL
C.	NULL
,	NULL
N.	NULL
Heintz	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1987	NULL
.	NULL

Purification	NULL
and	NULL
characterization	NULL
of	NULL
OTF-1	NULL
,	NULL
a	NULL
transcription	NULL
factor	NULL
regulating	NULL
cell	NULL
cycle	NULL
expression	NULL
of	NULL
a	NULL
human	NULL
histone	NULL
H2b	NULL
gene	NULL
.	NULL

Cell	NULL
51:773-781	NULL
.	NULL

Gerster	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
herpesvirus	NULL
trans-activating	NULL
protein	NULL
interacts	NULL
with	NULL
transcription	NULL
factor	NULL
OTF-1	NULL
and	NULL
other	NULL
cellular	NULL
proteins	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:6347-6351	NULL
.	NULL

Grosschedl	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1985	NULL
.	NULL

Cell-type	NULL
specificity	NULL
of	NULL
immunoglobulin	NULL
gene	NULL
expression	NULL
is	NULL
regulated	NULL
by	NULL
at	NULL
least	NULL
three	NULL
DNA	NULL
sequence	NULL
elements	NULL
.	NULL

Cell	NULL
41:885-897	NULL
.	NULL

Hanke	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
N.	NULL
F.	NULL
Landolfi	NULL
,	NULL
P.	NULL
W.	NULL
Tucker	NULL
,	NULL
and	NULL
J.	NULL
D.	NULL
Capra	NULL
.	NULL

1988	NULL
.	NULL

Identification	NULL
of	NULL
murine	NULL
nuclear	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
conserved	NULL
octamer	NULL
sequence	NULL
of	NULL
the	NULL
immunoglobulin	NULL
promoter	NULL
region	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:3560-3564	NULL
.	NULL

Herr	NULL
,	NULL
W.	NULL
,	NULL
R.	NULL
A.	NULL
Sturm	NULL
,	NULL
R.	NULL
G.	NULL
Clerc	NULL
,	NULL
L.	NULL
M.	NULL
Corcoran	NULL
,	NULL
D.	NULL
Baitimore	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
,	NULL
H.	NULL
A.	NULL
Ingraham	NULL
,	NULL
M.	NULL
G.	NULL
Rosenfeld	NULL
,	NULL
M.	NULL
Finney	NULL
,	NULL
G.	NULL
Ruvkun	NULL
,	NULL
and	NULL
H.	NULL
R.	NULL
Horvitz	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
POU	NULL
domain	NULL
:	NULL
a	NULL
large	NULL
conserved	NULL
region	NULL
in	NULL
the	NULL
mammalian	NULL
pit-1	NULL
,	NULL
oct-1	NULL
,	NULL
oct-2	NULL
,	NULL
and	NULL
Caenorhabditis	NULL
elegans	NULL
unc-86	NULL
gene	NULL
products	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

2:1513-1516	NULL
.	NULL

Hurwitz	NULL
,	NULL
R.	NULL
,	NULL
J.	NULL
Hozier	NULL
,	NULL
T.	NULL
LeBien	NULL
,	NULL
J.	NULL
Minowada	NULL
,	NULL
K.	NULL
Gajl-Peczalska	NULL
,	NULL
I.	NULL
Kubonishi	NULL
,	NULL
and	NULL
J.	NULL
Kersey	NULL
.	NULL

1979	NULL
.	NULL

Characterization	NULL
of	NULL
a	NULL
leukemic	NULL
cell	NULL
line	NULL
of	NULL
the	NULL
pre-B	NULL
phenotype	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
23:174-180	NULL
.	NULL

Ingraham	NULL
,	NULL
H.	NULL
A.	NULL
,	NULL
R.	NULL
Chen	NULL
,	NULL
H.	NULL
J.	NULL
Mangalam	NULL
,	NULL
H.	NULL
P.	NULL
Elsholtz	NULL
,	NULL
S.	NULL
E.	NULL
Flynn	NULL
,	NULL
C.	NULL
R.	NULL
Lin	NULL
,	NULL
D.	NULL
M.	NULL
Simmons	NULL
,	NULL
L.	NULL
Swanson	NULL
,	NULL
and	NULL
M.	NULL
G.	NULL
Rosenfeld	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
tissue-specific	NULL
transcription	NULL
factor	NULL
containing	NULL
a	NULL
homeodomain	NULL
specifies	NULL
a	NULL
pituitary	NULL
phenotype	NULL
.	NULL

Cell	NULL
55:519-529	NULL
.	NULL

Junker	NULL
,	NULL
S.	NULL
,	NULL
V.	NULL
Nielson	NULL
,	NULL
P.	NULL
Matthias	NULL
,	NULL
and	NULL
D.	NULL
Picard	NULL
.	NULL

1988	NULL
.	NULL

Both	NULL
immunoglobulin	NULL
promoter	NULL
and	NULL
enhancer	NULL
sequences	NULL
are	NULL
targets	NULL
for	NULL
suppression	NULL
in	NULL
myeloma-fibroblast	NULL
hybrid	NULL
cells	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

7:3093-3098	NULL
.	NULL

Kemler	NULL
,	NULL
I.	NULL
,	NULL
E.	NULL
Schreiber	NULL
,	NULL
M.	NULL
M.	NULL
Muller	NULL
,	NULL
P.	NULL
Matthias	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1989	NULL
.	NULL

Octamer	NULL
transcription	NULL
factors	NULL
bind	NULL
to	NULL
two	NULL
different	NULL
sequence	NULL
motifs	NULL
of	NULL
the	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
promoter	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:2001-2008	NULL
.	NULL

Kemp	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
and	NULL
D.	NULL
S.	NULL
Latchman	NULL
.	NULL

1988	NULL
.	NULL

Differential	NULL
regulation	NULL
of	NULL
octamer-containing	NULL
cellular	NULL
genes	NULL
by	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
virion	NULL
protein	NULL
Vmw65	NULL
is	NULL
mediated	NULL
by	NULL
sequence	NULL
differences	NULL
in	NULL
the	NULL
octamer	NULL
element	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

7:4239-4244	NULL
.	NULL

Knapp	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
Strober	NULL
,	NULL
C.-P.	NULL
Liu	NULL
,	NULL
P.	NULL
W.	NULL
Tucker	NULL
,	NULL
and	NULL
F.	NULL
R.	NULL
Blattner	NULL
.	NULL

1982	NULL
.	NULL

Simultaneous	NULL
expression	NULL
of	NULL
Cp	NULL
and	NULL
C	NULL
&	NULL
genes	NULL
in	NULL
a	NULL
cloned	NULL
B	NULL
cell	NULL
line	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
79:2996-3000	NULL
.	NULL

Ko	NULL
,	NULL
H.	NULL
,	NULL
P.	NULL
Fast	NULL
,	NULL
W.	NULL
McBride	NULL
,	NULL
and	NULL
L.	NULL
M.	NULL
Staudt	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
human	NULL
protein	NULL
specific	NULL
for	NULL
the	NULL
immunoglobulin	NULL
octamer	NULL
DNA	NULL
motif	NULL
contains	NULL
a	NULL
functional	NULL
homeobox	NULL
domain	NULL
.	NULL

Cell	NULL
55:135-144	NULL
.	NULL

LaBella	NULL
,	NULL
F.	NULL
,	NULL
H.	NULL
L.	NULL
Sive	NULL
,	NULL
R.	NULL
G.	NULL
Roder	NULL
,	NULL
and	NULL
N.	NULL
Heintz	NULL
.	NULL

1988	NULL
.	NULL

Cell-cycle	NULL
regulation	NULL
of	NULL
a	NULL
human	NULL
histone	NULL
H2b	NULL
gene	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
H2b	NULL
subtype-specific	NULL
consensus	NULL
element	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

2:32-39	NULL
.	NULL

Landolfi	NULL
,	NULL
N.	NULL
F.	NULL
,	NULL
J.	NULL
D.	NULL
Capra	NULL
,	NULL
and	NULL
P.	NULL
W.	NULL
Tucker	NULL
.	NULL

1986	NULL
.	NULL

Interaction	NULL
of	NULL
cell-type-specific	NULL
nuclear	NULL
proteins	NULL
with	NULL
the	NULL
immunoglobulin	NULL
V	NULL
;	NULL
promoter	NULL
region	NULL
sequences	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
323	NULL
:	NULL
548-551	NULL
.	NULL

Landolfi	NULL
,	NULL
N.	NULL
F.	NULL
,	NULL
X.-M.	NULL
Yin	NULL
,	NULL
J.	NULL
D.	NULL
Capra	NULL
,	NULL
and	NULL
P.	NULL
W.	NULL
Tucker	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
conserved	NULL
heptameric	NULL
sequence	NULL
upstream	NULL
of	NULL
the	NULL
IgH	NULL
promoter	NULL
region	NULL
octamer	NULL
can	NULL
be	NULL
the	NULL
site	NULL
of	NULL
a	NULL
coordinant	NULL
protein-DNA	NULL
interaction	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

16:5503-5515	NULL
.	NULL

LeBowitz	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
T.	NULL
Kobayashi	NULL
,	NULL
L.	NULL
Staudt	NULL
,	NULL
O.	NULL
Baltimore	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
.	NULL

1988	NULL
.	NULL

Octamer-binding	NULL
proteins	NULL
from	NULL
B	NULL
or	NULL
HeLa	NULL
cells	NULL
stimulate	NULL
transcription	NULL
of	NULL
the	NULL
immunoglobulin	NULL
heavy-chain	NULL
promoter	NULL
in	NULL
vitro	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

2:1227-1237	NULL
.	NULL

TRANSCRIPTION	NULL
OF	NULL
IMMUNOGLOBULIN	NULL
GENES	NULL
26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

989	NULL
Mackem	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
B.	NULL
Roizman	NULL
.	NULL

1982	NULL
.	NULL

Structural	NULL
features	NULL
of	NULL
the	NULL
herpex	NULL
simplex	NULL
virus	NULL
a	NULL
gene	NULL
4	NULL
,	NULL
0	NULL
,	NULL
and	NULL
27	NULL
promoter-regulatory	NULL
sequences	NULL
which	NULL
confer	NULL
a	NULL
regulation	NULL
on	NULL
chimeric	NULL
thymidine	NULL
kinase	NULL
genes	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

44:939-949	NULL
.	NULL

Maniatis	NULL
,	NULL
T.	NULL
,	NULL
E.	NULL
F.	NULL
Fritsch	NULL
,	NULL
and	NULL
J.	NULL
Sambrook	NULL
.	NULL

1982	NULL
.	NULL

Molecular	NULL
cloning	NULL
:	NULL
a	NULL
laboratory	NULL
manual	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
N.Y.	NULL
Mizushima-Sugano	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1986	NULL
.	NULL

Cell-type-specific	NULL
transcription	NULL
of	NULL
an	NULL
immunoglobulin	NULL
K	NULL
light	NULL
chain	NULL
gene	NULL
in	NULL
vitro	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
83:8511-8515	NULL
.	NULL

Muller	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
S.	NULL
Ruppert	NULL
,	NULL
W.	NULL
Schaffner	NULL
,	NULL
and	NULL
P.	NULL
Matthias	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
cloned	NULL
octamer	NULL
transcription	NULL
factor	NULL
stimulates	NULL
transcription	NULL
from	NULL
lymphoid-specific	NULL
promoters	NULL
in	NULL
non-B	NULL
cells	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
336:544-551	NULL
.	NULL

O'Hare	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
C.	NULL
R.	NULL
Goding	NULL
.	NULL

1988	NULL
.	NULL

Herpes	NULL
simplex	NULL
virus	NULL
regulatory	NULL
elements	NULL
and	NULL
the	NULL
immunoglobulin	NULL
octamer	NULL
domain	NULL
bind	NULL
a	NULL
common	NULL
factor	NULL
and	NULL
are	NULL
both	NULL
targets	NULL
for	NULL
virion	NULL
transactivation	NULL
.	NULL

Cell	NULL
52:435-445	NULL
.	NULL

O'Hare	NULL
,	NULL
P.	NULL
,	NULL
C.	NULL
R.	NULL
Goding	NULL
,	NULL
and	NULL
A.	NULL
Haigh	NULL
.	NULL

1988	NULL
.	NULL

Direct	NULL
combina-torial	NULL
interaction	NULL
betwen	NULL
a	NULL
herpes	NULL
simplex	NULL
virus	NULL
regulatory	NULL
protein	NULL
and	NULL
a	NULL
cellular	NULL
octamer-binding	NULL
factor	NULL
mediates	NULL
specific	NULL
induction	NULL
of	NULL
virus	NULL
immediate-early	NULL
gene	NULL
expression	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

7:4231-4238	NULL
.	NULL

O'Neil	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
and	NULL
T.	NULL
J.	NULL
Kelly	NULL
.	NULL

1988	NULL
.	NULL

Purification	NULL
and	NULL
characterization	NULL
of	NULL
nuclear	NULL
factor	NULL
III	NULL
(	NULL
origin	NULL
recognition	NULL
protein	NULL
C	NULL
)	NULL
,	NULL
a	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
protein	NULL
required	NULL
for	NULL
efficient	NULL
initiation	NULL
of	NULL
adenovirus	NULL
DNA	NULL
replication	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

263	NULL
:	NULL
931-937	NULL
.	NULL

Parslow	NULL
,	NULL
T.	NULL
,	NULL
D.	NULL
Blair	NULL
,	NULL
W.	NULL
Murphy	NULL
,	NULL
and	NULL
D.	NULL
Granner	NULL
.	NULL

1984	NULL
.	NULL

Structure	NULL
of	NULL
5	NULL
'	NULL
ends	NULL
of	NULL
immunoglobulin	NULL
genes	NULL
:	NULL
a	NULL
novel	NULL
conserved	NULL
sequence	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
81:2650-2654.	NULL
.	NULL

Poellinger	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1989	NULL
.	NULL

Octamer	NULL
transcription	NULL
factors	NULL
1	NULL
and	NULL
2	NULL
each	NULL
bind	NULL
to	NULL
two	NULL
different	NULL
functional	NULL
elements	NULL
in	NULL
the	NULL
immunoglobulin	NULL
heavy-chain	NULL
promoter	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9:747-756	NULL
.	NULL

Poellinger	NULL
,	NULL
L.	NULL
,	NULL
B.	NULL
K.	NULL
Yoza	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1989	NULL
.	NULL

Functional	NULL
cooperativity	NULL
between	NULL
protein	NULL
molecules	NULL
bound	NULL
at	NULL
two	NULL
distinct	NULL
sequence	NULL
elements	NULL
of	NULL
the	NULL
immunoglobulin	NULL
heavy-chain	NULL
promoter	NULL
.	NULL

Nature	NULL
337:573-576	NULL
.	NULL

Preston	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
M.	NULL
L.	NULL
Frame	NULL
,	NULL
and	NULL
M.	NULL
E.	NULL
M.	NULL
Campbell	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
complex	NULL
formed	NULL
between	NULL
cell	NULL
components	NULL
and	NULL
an	NULL
HSV	NULL
structural	NULL
polypeptide	NULL
binds	NULL
to	NULL
a	NULL
viral	NULL
immediate	NULL
early	NULL
gene	NULL
regulatory	NULL
DNA	NULL
sequence	NULL
.	NULL

Cell	NULL
52:425-434	NULL
.	NULL

Pruijn	NULL
,	NULL
G.	NULL
J.	NULL
M.	NULL
,	NULL
P.	NULL
C.	NULL
van	NULL
der	NULL
Vliet	NULL
,	NULL
N.	NULL
A.	NULL
Dathan	NULL
,	NULL
and	NULL
I.	NULL
W.	NULL
Mattaj	NULL
.	NULL

1989	NULL
.	NULL

Anti-OTF-1	NULL
antibodies	NULL
inhibit	NULL
NF	NULL
III	NULL
stimulation	NULL
of	NULL
in	NULL
vitro	NULL
adenovirus	NULL
DNA	NULL
replication	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17:1845-1861	NULL
.	NULL

Ryden	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
K.	NULL
Beeman	NULL
.	NULL

1989	NULL
.	NULL

Avian	NULL
retroviral	NULL
long	NULL
terminal	NULL
repeats	NULL
bind	NULL
CCAAT/enhancer-binding	NULL
protein	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9:1155-1164	NULL
.	NULL

Scheidereit	NULL
,	NULL
C.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Cromlish	NULL
,	NULL
T.	NULL
Gerster	NULL
,	NULL
K.	NULL
Kawakami	NULL
,	NULL
C.	NULL
Balmaceda	NULL
,	NULL
R.	NULL
A.	NULL
Currie	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
human	NULL
lymphoid-specific	NULL
transcription	NULL
factor	NULL
that	NULL
activates	NULL
immunoglobulin	NULL
genes	NULL
is	NULL
a	NULL
homeobox	NULL
protein	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
336	NULL
:	NULL
551-556.	NULL
.	NULL

Scheidereit	NULL
,	NULL
C.	NULL
,	NULL
A.	NULL
Heguy	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1987	NULL
.	NULL

Identification	NULL
and	NULL
purification	NULL
of	NULL
a	NULL
human	NULL
lymphoid-specific	NULL
octamer-binding	NULL
protein	NULL
(	NULL
OTF-2	NULL
)	NULL
that	NULL
activates	NULL
transcription	NULL
of	NULL
an	NULL
immunoglobulin	NULL
promoter	NULL
in	NULL
vitro	NULL
.	NULL

Cell	NULL
§1:783-793	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1987	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
of	NULL
immunoglobulin	NULL
genes	NULL
in	NULL
a	NULL
B-cell	NULL
extract	NULL
:	NULL
effects	NULL
of	NULL
enhancer	NULL
and	NULL
promoter	NULL
sequences	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7:1989-1994	NULL
.	NULL

Skuzeski	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
E.	NULL
Lund	NULL
,	NULL
J.	NULL
T.	NULL
Murphy	NULL
,	NULL
T.	NULL
H.	NULL
Steinberg	NULL
,	NULL
R.	NULL
R.	NULL
Burgess	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Dahlberg	NULL
.	NULL

1984	NULL
.	NULL

Synthesis	NULL
of	NULL
human	NULL
U1	NULL
RNA	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

259:8345-8352	NULL
.	NULL

Smith	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
Y.	NULL
G.	NULL
Dev	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
Shannon	NULL
,	NULL
Jr.	NULL
1981	NULL
.	NULL

Characterization	NULL
of	NULL
a	NULL
novel	NULL
human	NULL
pre-B	NULL
leukemia	NULL
cell	NULL
line	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

126:596-601.	NULL
.	NULL

Staudt	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
R.	NULL
G.	NULL
Clerc	NULL
,	NULL
H.	NULL
Singh	NULL
,	NULL
J.	NULL
H.	NULL
LeBowitz	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

Cloning	NULL
of	NULL
a	NULL
lymphoid-specific	NULL
cDNA	NULL
encoding	NULL
a	NULL
protein	NULL
binding	NULL
the	NULL
regulatory	NULL
octamer	NULL
DNA	NULL
motif	NULL
.	NULL

Science	NULL
241:577-580	NULL
.	NULL

Staudt	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
H.	NULL
Singh	NULL
,	NULL
R.	NULL
Sen	NULL
,	NULL
T.	NULL
Wirth	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
,	NULL
and	NULL
D.	NULL
990	NULL
47	NULL
.	NULL

49	NULL
.	NULL

JOHNSON	NULL
ET	NULL
AL	NULL
.	NULL

Baltimore	NULL
.	NULL

1986	NULL
.	NULL

A	NULL
lymphoid-specific	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
octamer	NULL
motif	NULL
of	NULL
immunoglobulin	NULL
genes	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
323	NULL
:	NULL
640-643.	NULL
.	NULL

Sturm	NULL
,	NULL
R.	NULL
,	NULL
T.	NULL
Baumruker	NULL
,	NULL
B.	NULL
R.	NULL
Franza	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
W.	NULL
Herr	NULL
.	NULL

1987	NULL
.	NULL

A	NULL
100	NULL
kD	NULL
HeLa	NULL
cell	NULL
octamer	NULL
binding	NULL
protein	NULL
(	NULL
OBP100	NULL
)	NULL
interacts	NULL
differently	NULL
with	NULL
two	NULL
separate	NULL
octamer-related	NULL
sequences	NULL
within	NULL
the	NULL
SV40	NULL
enhancer	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

1:1147-1160	NULL
.	NULL

Sturm	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
G.	NULL
Das	NULL
,	NULL
and	NULL
W.	NULL
Herr	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
ubiquitous	NULL
octamer-binding	NULL
protein	NULL
Oct-1	NULL
contains	NULL
a	NULL
POU	NULL
domain	NULL
with	NULL
a	NULL
homeo	NULL
box	NULL
subdomain	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

2:1582-1599.	NULL
.	NULL

Sturm	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
W.	NULL
Herr	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
POU	NULL
domain	NULL
is	NULL
a	NULL
bipartite	NULL
DNA-binding	NULL
structure	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
336:601-604	NULL
.	NULL

Tanaka	NULL
,	NULL
M.	NULL
,	NULL
U.	NULL
Grossniklaus	NULL
,	NULL
W.	NULL
Herr	NULL
,	NULL
and	NULL
N.	NULL
Hernandez	NULL
.	NULL

1988	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
U2	NULL
snRNA	NULL
promoter	NULL
by	NULL
the	NULL
octamer	NULL
motif	NULL
defines	NULL
a	NULL
new	NULL
class	NULL
of	NULL
RNA	NULL
polymerase	NULL
II	NULL
enhancer	NULL
elements	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

2:1764-1778	NULL
.	NULL

Tokahashi	NULL
,	NULL
N.	NULL
,	NULL
S.	NULL
Nakai	NULL
,	NULL
and	NULL
T.	NULL
Honjo	NULL
.	NULL

1980	NULL
.	NULL

Cloning	NULL
of	NULL
human	NULL
immunoglobulin	NULL
p	NULL
gene	NULL
and	NULL
comparison	NULL
with	NULL
mouse	NULL
p	NULL
gene	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

8:5983-5991	NULL
.	NULL

Wirth	NULL
,	NULL
T.	NULL
,	NULL
L.	NULL
Staudt	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1987	NULL
.	NULL

An	NULL
octamer	NULL
oligonucleotide	NULL
upstream	NULL
of	NULL
a	NULL
TATA	NULL
motif	NULL
is	NULL
sufficient	NULL
for	NULL
lymphoid-specific	NULL
promoter	NULL
activity	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
329:174-178	NULL
.	NULL

Zack	NULL
,	NULL
J.	NULL
,	NULL
R.	NULL
G.	NULL
Smith	NULL
,	NULL
and	NULL
B.	NULL
Ozanne	NULL
.	NULL

1987	NULL
.	NULL

Characterization	NULL
of	NULL
a	NULL
leukemia-derived	NULL
transforming	NULL
growth	NULL
factor	NULL
.	NULL

Leukemia	NULL
1	NULL
:	NULL
737-745	NULL
.	NULL

Zaller	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
H.	NULL
Yu	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Eckhardt	NULL
.	NULL

1988	NULL
.	NULL

Genes	NULL
activated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
immunoglobulin	NULL
enhancer	NULL
or	NULL
promoter	NULL
are	NULL
negatively	NULL
regulated	NULL
by	NULL
a	NULL
T-lymphoma	NULL
cell	NULL
line	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:1932-1939	NULL
.	NULL

